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ABSTRACT 
Electrospray ionization mass spectrometry (ESI-MS)-based assays have been newly 
developed to study three classes of enzymes (sugar nucleotidyltransferases, 
glycosyltransferases, and phosphorylases) from the three distinct families of life: archaea, 
eukaryotes, and prokaryotes. These three classes of enzymes play vital roles in carbohydrate 
storage, degradation and synthesis. The sugar nucleotidyltransferases from Escherichia coli 
and yeast that bio synthesize UDP-glucose and ADP-glucose respectively were studied using 
the first ESI-MS assay. Nonlinear regression of the kinetic data was comparable to those 
determined from the traditional UDP-glucose dehydrogenase-coupled assay. This technique 
allowe us to determine that the yeast sugar nucleotidyltransferase has one binding site that 
biosynthesizes both ADP-glucose and UDP-glucose. 
A related assay was applied to the study of glycogen synthases from rabbit, yeast, and the 
first archaeal glycogen synthase from P. furiosus. Unlike the specificity seen in the rabbit and 
yeast enzymes, the P. furiosus glycogen synthase did not differentiate substrates on the basis 
of the nucleotide but on the structure of the carbohydrate. The P. furiosus glycogen synthase 
showed broad acceptance of ADP-, dTDP-, GDP-, and UDP-glucose while not accepting 
UDP-galactose. Competition binding experiments demonstrated that for both the rabbit 
muscle and P. furiosus glycogen synthases the alpha-phosphate is the most important feature 
for binding between the substrate and biocatalyst. Through ESI-MS analysis, the kinetic 
parameters KM, Vmax, and K, (for a/p-D-glucose) also were determined for an enzyme 
responsible for degrading glycogen polymers. The rabbit muscle phosphorylase b accepted 
xiv 
maltoheptaose, maltohexaose, and maltopentaose but not maltotetrose as substrates in the 
direction of glycogen phosphorylysis. 
Many biocatalysts, in particular sugar nucleotidyltransferases, depend on metals for full 
catalytic activity; however the role they play is not well understood. Using isothermal 
titration calorimetry (ITC) we have studied the binding relationship between the divalent 
metals, magnesium and manganese, and uridine-5'-phosphates to determine the role these 
metals play in carbohydrate biosynthesis. The binding constant associated with the 
coordination of Mg+2 and Mn+2 to the phosphate was shown to follow the pattern of 
PP,>UTP>UDP>UMP~UDP-Glc~Glc-l-P. Through the use of ESI-MS and ITC we have 
begun to explore the binding relationship between the substrate and the biocatalyst. 
1 
CHAPTER 1. Introduction 
Introduction 
The complete sequencing of numerous genomes opens the door to finally understanding the 
role biocatalysts play in a variety of biochemical pathways as well as the ability to compare 
functionality across genomes.1 The understanding of the function of biocatalysts is of 
particular interest for the development of new chemoenzymatic strategies for pharmaceutical 
and other syntheses.2 However, with so many new biocatalyst possibilities, the discovery and 
characterization of biocatalysts is becoming the limiting factor. Initial biocatalytic functions 
can be based solely on sequence alignment of the genome; however, biochemical 
characterization is necessary to verify these postulated functions and explore the substrate 
scope, heat stability, and other useful parameters of new proteins. 
This need for chemical function analysis of new proteins is highlighted by a class of 
biocatalysts, glycosyltransferases, that are responsible for transferring the carbohydrates that 
denote human A and B blood groups. These biocatalysts are structurally highly similar, 
differing in only 4 of 354 amino acids.3,4 Yet this subtle difference allows for the high 
selectivity necessary to differentiate between the transfer of galactose or N-
acetylgalactosamine3 or, in the case of a mutation in one key amino acid, the lack of 
carbohydrate transfer.4 Because of the potential for biocatalysts to be structurally highly 
conserved, and yet differ in substrate selectivity, it is necessary to isolate and characterize 
each one with complete structure-function relationships. While the process for biocatalyst 
isolation has become easier with the development and improvement of many current cloning 
2 
and expression protocols, the rate-determining step is how quickly one is able to fully 
characterize the substrate tolerance and kinetic parameters of the biocatalyst in question. The 
optimal method would be one that can be applied to multiple systems and is capable of high 
throughput. The conservation of biocatalysts across organism types, class of biocatalysts 
studied as well as assays used in the characterization of biocatalysts of interest will be 
discussed below. 
Genomic Similarities of Biocatalysts 
Classification of biocatalysts begins by defining the source of the biocatalysts. Different cell 
types compartmentalize cellular functions differently and this attribute can dictate the cellular 
function and substrate selectivity of biocatalysts. In 1990, Woese et al. redefined the 
definition of organism types and organized them into three primary groups, archaea (or 
archaeabacteria), bacteria (or eubacteria), and eukarya (or eukaryotes).5 Metabolic 
biocatalysts in archaea are more often similar to homologous biocatalysts in bacteria than in 
eukarya.6 However, the cellular organization (transcription, translation, and replication) in 
archaea is more similar to eukarya. However, relatively little is known of archaeal proteins 
and pathways. Because metabolic pathways are not highly conserved within and some main 
pathways are not even present in some archaea,7'8 researchers are eager to study various 
archaea to further understand the perhaps unique characteristics from various archaeal 
sources. 
3 
Role of Divalent Metals in Carbohydrate Biocatalysis 
Many biocatalysts require divalent metals for full activity. In carbohydrate biosynthesis, the 
divalent metal ion requirements for catalysis has been well documented in systems that 
activate sugars, sugar nucleotidyltransferases,9 and those that transfer sugars, 
glycosyltransferases.10 Sugar nucleotidyltransferases are known to require divalent 
magnesium for activity9 while some glycosyltransferases are manganese dependent.10 Even 
though these systems are very metal-specific, often they are able to function in the presence 
of other divalent metals with reduced activity.9 Although the role divalent metals play is well 
known, the relationship of the metal to the substrate or enzyme is not well understood. 
Divalent magnesium has also been shown to play a role in certain metabolic disorders. It was 
noted with decreased serum magnesium concentrations there was an increased incidence of 
type 2 diabetes mellitus and high blood pressure.9 Administration of oral magnesium chloride 
showed an increase in serum magnesium levels with a subsequent increase in insulin 
sensitivity and decrease in total cholesterol.12"15 The process by which magnesium is able to 
assist in the regulation of blood glucose levels and lower total cholesterol is not clear. 
However, this observed outcome might arise due to magnesium increasing the substrate 
binding to the biocatalyst or increasing biocatalytic activity in another manner. 
Biocatalysts Involved in Carbohydrate Biosynthesis 
One of the oldest studied biochemical pathways having biological importance across all life 
is the pathway that activates glucose-1-phosphate, polymerizes it into glycogen or starch, and 
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degrades the glucose polymer into glucose-1 -phosphate (Scheme 1.1). Because of its 
important role in glucose regulation this pathway has been targeted for the potential 
understanding substrate recognition by studying the biocatalysts along this pathway. The 
manner in which the biocatalyst recognizes it substrate can dictate the parameters necessary 
for catalytic activity as well as point to new directions for the development of inhibitors and 
drug candidates. Current assays used to measure biocatalytic activity of each class of 
biocatalysts will be discussed later. 
Scheme 1.1. Biochemical pathway for the activation, transfer, and regeneration of glucose-1-
phosphate. Allosteric regulation of glycogen synthase and phosphorylase b is not conserved 
across all families. 
Sugar Nucleotidyltransferase. The activated glycosyl donors that are required by hundreds of 
different glycosyltransferases are biosynthesized by a class of enzymes called sugar 
nucleotidyltransferases (Scheme 1.2). These enzymes catalyze the formation of nucleotide 
diphospho sugars from sugar-1-phosphates and nucleotide triphosphates. 
treatment of diabetes and target of antibiotics.16"22 Therefore, much is hoped to gain in 
Phosphoglucomutase 
Hexokinase 
Phosphorylase b Sugar 
Nucleotidyl­
transferase 
OH 
Glycogen 
Synthase O^ .OUDP 
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Nucleotidyltransferases are metal-dependant enzymes requiring Mg+2 for full activity9 and 
are known to be inhibited by UTP, UDPG, and PP,.9 Since this enzyme class activates 
various sugars for glycosyl transfer, it is targeted as a biocatalyst that may allow for the 
biosynthesis of non-natural compounds.23 However, this class of enzymes is typically very 
substrate-specific; therefore, numerous researchers are trying to ascertain the substrate 
specificity of numerous sugar-NT's for natural and non-natural sugars.24"30 
OH 
.0 
O h _ 
o-p-o 
OH 
O" 
HO^ + 
Sugar-1-
Phosphate 
Sugar NT .0 
0 II p-0 
0 > II 
-p-o-
0 II 
-p-
CT cr 
NTP 
cr 
R' 
HO 
o o Il II 
0-P-0-P-0 
6" o" 
NDP-sugar 
+ 
Pyrophosphate 
R' 
HO R" 
HO R" 
Scheme 1.2. General reaction diagram for the biosynthesis of NDP-sugar from sugar-1-
phosphate in the presence ofNTP, where R' = A, C, G, T, U and R" = H or OH. 
-O 
NDP 
Activated 
Sugar 
Polysaccharide 
Synthase -O O 
Sugar 
Polymer 
Scheme 1.3. General reaction diagram for a type of glycosyltransferases that transfers a 
sugar, as NDP-sugar, to another sugar thereby creating a carbohydrate polymer. 
Glycogen Synthase. Glycogen and starch biosynthesis occurs via biocatalysts that fall under 
the category of glycosyltransferases (Scheme 1.3). These biocatalysts play important roles in 
many biological functions including protein activation and cell-cell communication,31'32 ABO 
blood group designation,3'4 and the storage of glucose in the form of glycogen or starch. 33 
6 
Glycosyltransferases fit into two distinct classes: GT-A and GT-B. Biocatalysts that belong 
to the category GT-A have been shown to be metal dependant, particularly for Mn+2, whereas 
GT-B's are not metal dependant.10 Biocatalysts involved in glycogen and starch biosynthesis 
belong to the class of GT's that are not metal dependant. 
Starch and its analog glycogen are biosynthesized by enzymes that typically utilize UDP- or 
ADP-glucose as the carbohydrate source. Glycogen biosynthesis has been shown to be 
regulated by the allosteric activator, glucose-6-phosphate, and inhibited by the product, 
UDP,34 whereas starch biosynthesis in green algae and higher plants is inhibited by 
phosphate and ADP.35 These biocatalysts have been classified by sequence similarities into 
two families that have no significant sequence overlap: the animal/fungal glycogen synthases 
and the plant/bacterial glycogen (starch) synthases.33 These two classes of glycogen and 
starch synthases have been shown to demonstrate different substrate selectivities as 
evidenced by animal/fungal glycogen synthases accepting UDP-glucose33 and plant/bacterial 
glycogen (starch) synthases accepting ADP-glucose as substrates.33 However, this high 
substrate selectivity may not be true of archaeal glycogen synthases. There is recent evidence 
from impure protein preparations of archaeal glycogen synthases accept both ADP- and 
UDP-glucose.36'37 This is not yet conclusive and still needs to be investigated with a pure 
archaeal glycogen synthase. 
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Phosphorylase Sugar 
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—
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Sugar-1-phosphate V> + + 
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Scheme 1.4. General reaction diagram for the cleavage of sugar linkages by phosphate. 
Phosphorylase. In the presence of phosphate, phosphorylases reversibly cleave carbohydrate 
bonds to form sugar-1 -phosphates (Scheme 1.4). Evidence for proteins that cleave sugar 
linkages by phosphate is found in a broad range of genomes for a wide variety of reactions 
including the breakdown of maltose, trehalose, sucrose, uridine and thymidine as well as 
carbohydrate polymers such starch and glycogen.38"45 In particular, phosphorylase b was first 
isolated from rabbit muscle by Cori and Cori and shown to catalyze the reversible conversion 
of glycogen into glucose-1-phosphate.38 Previous studies of phosphorylase b from rabbit 
muscle have shown its activity to be dependant on the degree of phosphorylation of the 
enzyme. The enzyme also was shown to be allosterically activated by AMP and inhibited by 
ATP in the direction of glycogen degredation,46 as well as inhibited by glucose in the 
direction of glycogen synthesis.46 Because the synthesis and degradation of glycogen is 
important in the regulation of blood glucose levels,47'48 phosphorylase b has been the target 
of inhibitor design for the treatment of diabetes.20,21,48,49 
Due to the nature of phosphorylase b, it can be studied in the direction of glycogen synthesis 
or glycogen degradation. However, under physiological conditions the biologically relevant 
direction is that of glycogen degradation. While most of the substrate specificity studies have 
8 
been done the direction of glycogen synthesis demonstrating that primer units of three or 
more glucose units are necessary for glycogen elongation,50'51 the minimal unit necessary for 
the recognition and degradation of glycogen by phosphorylase b in the presence of phosphate 
is still unclear. This understanding would aid in the search for the potential of inhibitors of 
phosphorylase b. 
Assays Used in Monitoring Carbohydrate Biocatalysis 
Carbohydrate biocatalysts have been studied widely over the past century; in contrast to 
some biochemical systems, the quantitative detection of carbohydrate substrates is 
challenging. To study these biocatalysts, many different assay methods have been developed. 
They have included the use of radiolabeled compounds,52"58 UV-VIS,54,59 coupled assays,60"64 
HPLC,29 30'53 and most recently ESI-MS.65"77 
Radiolabeled Compounds. The quantification of enzymatic reactions using radiolabeled 
compounds has been used for many biochemical systems including sugar 
nucleotidyltransferases52'53 and glycogen and starch synthases.55"58 The main advantage of 
this technique is the sensitivity afforded the detection of radioactive compounds. The use of 
radioactively labeled compounds is limited by their high cost and need for special safety 
precautions and regulations. Also, any additional labeled substrates that are not commercially 
available need to be synthesized, as task that requires carrying a radioactively labeled 
substrate though a multi-step synthesis that inevitably also generates radioactive waste. 
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Coupled Assays. Coupled assays utilize additional biocatalysts to act upon compounds, either 
a product or remaining starting material of the enzymatic reaction of question, to produce a 
substrate that can be easily quantified typically by UV-VIS. For the study of carbohydrate 
biosynthesis typical coupled assays used include the UDP-glucose dehydrogenase61 and the 
phosphoglucomutase/glucose-6-phosphate dehydrogenase61 systems (Scheme 1.5). The 
compound quantified in these systems is not the original compound in question, but is 
NADH, which is produced via oxidation of the compound with reduction of NAD+ to 
NADH. Other coupled assay systems60,62 have been developed with improved sensitivities or 
system capabilities, but since these systems are not yet commercially available they require 
the expression and purification of numerous enzymes and in some instances these assays 
monitor the reaction in the non-biologically relevant direction. 
6-phosphogluconate 
UDP-glucuronic acid 
Scheme 1.5 Coupled assays used for the quantitation of (A) glucose and (B) UDP-glucose. 
UV-VIS. Since coupled assays are dependent on the substrate recognition and turnover of a 
second enzyme it limits the ability to study atypical substrates. Therefore, it is essential to 
(A) 
Glucose 
Hexokinase 
ATP ADP 
Glucose-6-phosphate 
Glucose-6-phosphate 
Dehydrogenase 
NAD NADH 
(B) 
UTP 
Sugar NT 
Glucose-1 -phosphate UDP-glucose 
UDP-glucose 
Dehydrogenase 
2 NAD+ 2 NADH 
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have multiple assays for multiple sugar-nucleotide systems. The indirect readout using 
additional enzymes that act on glucose also complicates the screening of carbohydrate-like 
inhibitors. Whereas UV-VIS spectroscopy is most often combined with coupled assays to 
study enzymatic reactions, it has been used independently to monitor the formation of 
phosphate in the study of phosphorylase b. However, this technique requires the system to be 
studied in the direction of glycogen synthesis rather than in the biologically relevant direction 
of glycogen degradation. 
HPLC. Recently, Thorson and coworkers have used HPLC separation and quantitation of 
reaction components extensively to study the substrate recognition capabilities of sugar 
AQ Z\ 
nucleotidyltransferases with natural and synthetic substrates. ' ' Unlike the case of the 
coupled assay, this technique can be adapted to separate many compounds from many 
different systems. However, new separation protocols must be developed for each new 
substrate and HPLC runs require long separation times for substrate separation and 
quantitation. This fact severely limits the practicality of HPLC to be used in obtaining kinetic 
information because of the requirement for multiple data points and this technique is not 
amenable to high through put screening. 
ESI-MS. The use of electrospray ionization mass spectrometry as a technique in the study of 
enzyme kinetics is becoming more prevalent in recent years.65"77 This approach to enzyme-
substrate characterization is advantageous over other techniques because of the ability to 
simultaneously monitor all charged species involved in the reaction of interest without 
11 
purification and sidesteps the issues that are found with substrate requirements for coupled 
assays, radioactively labeled compounds, HPLC separation protocols, and chromophore 
requirements for UV-VIS analysis. An added bonus is that this technique is amenable to high 
throughput sample screening, thereby allowing for the rapid characterization of substrate 
tolerance and in particular kinetic parameters such as KM, Vmax, and K,. However, efficient 
and reproducible substrate ionization protocols that are compatible with particular enzymatic 
reaction conditions must be discovered. 
Because of the enormous task it would take to determine empirically the function of each 
gene from every source, it would be advantageous to have a technique that is able to rapidly 
assay biocatalytic activity. Although numerous new systems have been developed to better 
study carbohydrate biocatalysis, no new characterization method has been developed that is 
capable of high throughput screening and is general. 
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CHAPTER 2. Thermodynamics of Binding of Divalent Magnesium and 
Manganese to Uridine Phosphates: Implications for Diabetes-Related 
Hypomagnesemia and Carbohydrate Biocatalysis 
Corbin J. Zea1,2 and Nicola L. Pohl1'3 
Abstract 
Using isothermal titration calorimetry we have studied the binding relationship between the 
divalent metals, magnesium and manganese, and uridine 5'-phosphates. The binding constant 
and free energy of binding between metal and phosphate follow the pattern (PP, > UTP > 
UDP > UMP ~ UDP-Glc ~ Glc-l-P). Divalent manganese was found to more tightly bind PP* 
and UTP than divalent manganese. However, due to the low intercellular concentration of 
manganese, phosphate is not found to bind to manganese while 96% of UTP and 98% of PP, 
would be bound to divalent magnesium at physiological conditions. With these data, we 
discuss the role of magnesium and manganese in nucleotidyltransferase, glycosyltransferase, 
and glycogen phosphorylase reactions and the implications for drug design. 
1 Graduate student and Assistant Professor, respectively, Department of Chemistry and the 
Plant Sciences Institute, Iowa State University 
2 Primary researcher and an author 
3 Author for correspondence 
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Introduction 
The roles that nucleotides play in cellular metabolism range in scope from their use as 
enzyme substrates to regulators for numerous biochemical pathways. Because of their 
biological importance and the requirement of divalent metals for biological activity, the 
binding relationship between various metals and nucleotides has been well documented to 
shed light on the role of metal-nucleotide complexes in the conformational changes that 
occur in DNA biosynthesis1"5 and the energy pathways that involve ATP.6"13 
Recent studies suggest that certain metabolic disorders are linked to serum magnesium 
concentrations in a way that can be explained by these relative metal-binding equilibria. For 
example, individuals with hypomagnesemia—reduced serum magnesium concentration— 
have an increased incidence of metabolic disorders such as type 2 diabetes mellitus and high 
blood pressure.14 Simple oral administration of magnesium chloride can increase serum 
magnesium concentrations and decrease total cholesterol and HDL levels while increasing 
LDL and insulin sensitivity in these patients.15"18 In patients with high cholesterol and 
hypomagnesemia, the effectiveness of magnesium treatment is attributed to increasing the 
efficacy of statin pharmaceuticals by shifting the equilibrium to the formation of a Mg+2-ATP 
complex which is necessary intermediate in the cholesterol biosynthetic pathway.19 
Surprisingly, searches for an explanation of the effect of magnesium supplementation on 
insulin levels so far have focused only on metal effects at the DNA level1"5 and not on the 
effects of metals on the relative amounts of the substrates involved in glucose metabolism. 
20 
The biochemical pathway that synthesizes glycogen and degrades it (Scheme 2.1) plays an 
important role in cellular function and metabolism. This pathway is responsible for the 
storage of glucose and glycogen as well as the regulation of blood glucose levels. For this 
reason glycogen synthase as well as phosphorylase b have been targets of diabetic drug 
targets.20"23 It has also been shown that the biocatalyst that activates glucose as ADP-glucose 
in plants plays a regulatory role in starch biosynthesis24"26 which tags all three biocatalysts as 
contributing to the regulation of glucose concentrations. 
Hexose-1 -phosphate 
Nucleotidyltransferase 
(Glucose-1 -phosphate 
Uridyltransferase) 
oh oh 
nh HO" 
ho ho HO o-p-o-p-o i+2 o-p-o 
utp 
Glucose-1 -phosphate UDP-giucose ho oh 
oh 
Mn 
oh ho Glycosyltransferase 
(Glycogen Synthase) ho Phosphorylase 
(Phosphorylase b) oh ho ho UDP 
Glycogen HO HO 
Scheme 2.1. Biochemical pathway for the synthesis and degradation of glycogen. General 
classification and the specific names of biocatalysts associated with carbohydrate 
biosynthesis are shown. 
While it is widely known that divalent cations, in particular Mg+2 and Mn+2, play a very 
important role in carbohydrate biocatalysis, the actual mechanism by which the metal 
interacts with the ligand and the enzymes is not clearly understood. This has important 
implications in drug development when one needs to be concerned with whether the cation 
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generally binds first to the active site or the ligand before ligand binding to the protein is 
achieved. 
The relationship between the binding of substrates and subsequent catalysis or inhibition is 
not clearly understood. While it is well documented that uridine triphosphate (UTP), 
pryophosphate (PP*), glucose-1 -phosphate (Glc-l-P), and uridine diphosphate glucose (UDP-
Glc) all bind and act as inhibitors,27"30 uridine diphosphate (UDP) was demonstrated by 
Gillett and coworkers31 to not bind to UDP-Glc pyrophosphorylase. This result is confusing 
since other researchers have determined UDP to be an inhibitor of UDP-Glc 
pyrophosphorylase.28,29 This raises the question how is inhibitor binding related to inhibitory 
affect. Herein, we discuss the binding of Mg+2 and Mn+2 with UTP, UDP, uridine 
monophosphate (UMP), UDP-Glc, and PP, in order to gain an understanding in how and why 
sugar nucleotidyl transferases and glycosyltransferases (type B) are metal dependant, and to 
determine in what order metal binding occurs (i.e. does the metal bind to the ligand or 
biocatalyst first) and what role that has on catalytic activity or inhibition. 
Results and Discussion 
While the binding of Mg+2 to nucleotide phosphates has been studied previously,6,8'13 the 
binding relationship between the metals, Mg+2 and Mn,+2 and uridine phosphates have not 
been described. Because the primary interaction between the metal and nucleotides occurs 
between the phosphates and the metal one would expect the binding parameters between 
ATP and UTP to be similar. It would also be expected that little binding would be lost by the 
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addition of glucose to UDP to form UDP-giucose. The thermodynamics of binding of Mg+2 
and Mn+2 to UTP, UDP, UMP, UDP-Glc, Glc-l-P, and PP, were determined at the 
physiological relevant temperature of 37 °C by the use of ITC by the direct titration of a 
solution of magnesium or manganese (II) chloride into a solution containing the phosphate 
containing compound being studied. It was determined from the isothermal titration 
calorimetry (ITC) data that Mg+2 and Mn+2 are most tightly bound to PP;, Kb = 41,000 ± 2000 
M"1 and 28,000 ± 50,000 M"1 respectively, and UTP, Kb = 14,300 ± 700 M"1 and 13,000 ± 
2,000 M"1 respectively (Figure 2.1). The binding parameters determined for the binding of 
Mg+2 and Mn+2 to UDP and UMP were found to be less than that of UTP. The degree of 
association between Mg+2 and Mn+2 decreases as phosphates are removed (UTP > UDP > 
UMP). However as expected the binding parameters measured were comparable to 
previously reported results for the binding of Mg+2 to ATP, ADP, AMP, and UMP.6"8'10 
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Figure 2.1. Binding constants of phosphates bound to Mg+2 (white) and Mn+2 (gray). 
Comparison of the binding constants for the binding of Mg+2 and Mn+2 to UDP-Glc to the 
binding of Mg+2 and Mn+2 to UDP affords an approximately 10-fold decrease in binding. 
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This significant decrease in binding due to the addition of glucose was not expected. 
Whereas the binding values associated with the binding of Mg+2 and Mn+2 to Glc-l-P were 
found to be similar in strength to the binding of Mg+2 and Mn+2 to UMP. This data suggests 
that the binding of Mg+2 and Mn+2 to phosphates is dependant on the binding environment of 
the phosphates involved in the coordination of the metals, Mg+2 and Mn+2. Looking at the 
binding constants the following pattern emerges (PP; > UTP > UDP > UMP ~ UDP-Glc ~ 
Glc-l-P). This data demonstrate a great effect of the subsrates proximity to the binding 
phosphate. If the phosphate has no substrates bound, as in the case of PP„ the binding 
constant is large, while in the case of UMP, UDP-Glc, and Glc-l-P, where the substrate is 
bound directly to the binding phosphate, the binding constant is significantly smaller. 
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Figure 2.2. Free energy of binding of phosphates to Mg+2 (white) and Mn+2 (gray) as 
determined by AG = AH - TAS. 
Thermodynamic values (Figure 2.2) for the titrations were determined and for all cases 
except for the titration of pyrophosphate by Mg+2 and Mn+2, the binding enthalpies were 
endothermic. All titrations afforded a positive change in entropy, which correlates to an 
increase in disorder caused by the loss of a water shell around the metal and phosphate 
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compound as the metal coordinates to the phosphate compound. This increase in disorder 
allowed the overall coordination of Mg+2 and Mn+2 to the phosphate to be thermodynamically 
allowed with the free energy following a similar pattern as the binding values (PP, > UTP > 
UDP > UMP ~ UDP-Glc ~ Glc-l-P). 
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Figure 2.3. Percent of phosphate bound to Mg+2 (white) at the intracellular concentration of 
1.5 mM. No measurable binding is observed for Mn+2. 
Although Mg+2 and Mn+2 bind at very similar strengths to phosphates, the intracellular 
concentrations of Mg+2 and Mn+2 vary greatly. Given intracellular concentrations of Mg+2 
and Mn+2 of 1.5 mM32 and 10 nM33 respectively, the amount of phosphate bound to Mg+2 and 
Mn+2 varies greatly as shown in Figure 2.3. At these concentrations the concentration of 
Mn+2 is not large enough to shift the equilibrium of binding in the direction of metal-
phosphate complex formation. However, all of the phosphates show a measurable degree of 
binding to Mg+2 at intracellular concentrations of Mg+2. Uridine triphosphate and PP; are 
almost completely bound (> 95%) to Mg+2 at intracellular concentrations of Mg+2, while 
UDP is mostly bound (83%), and UMP, UDP-Glc, and Glc-l-P are only partially bound to 
Mg+2(~25%). 
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Figure 2.4. Percent of phosphate bound to Mg+2 at a normal physiological Mg+2 
concentration of 1.5 mM (white) and at a hypomagnesemia concentration of 0.7 mM (gray). 
When the concentration of magnesium decreases, as is the case in hypomagnesemia (0.7 mM 
Mg+2) there can be significant changes in the phosphate-magnesium concentration (Figure 
2.4). In cases where Mg+2 is tightly bound, PP, and UTP, there is not a large change in 
complex formation. However, when the binding is not as tight, as is the case with UDP, 
UMP, UDP-Glc, and Glc-l-P, the concentration of the phosphate-magnesium complex is 
greatly reduced by the change in magnesium ion concentration associated with 
hypomagnesemia. This decrease in magnesium-phosphate complex formation would lead to 
decreased activity of glycogen synthase because of the role that AMP plays as an allosteric 
activator as well as decreasing the activity of phosphorylase b which is alosterically activated 
by glucose-6-phosphate. 
Biological Implications 
To understand the role that metal binding plays in enzymatic activity we analyzed known 
crystal structures of sugar NTs,34"43 GT-As,44-54 and GT-Bs.55-62 The active site analysis of 
sugar NT crystal structures revealed the metal ion, Mg+2, ligands to be one to two oxygen 
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atoms from the phosphates and two to three coordinated oxygens from aspartic acid residues 
from the enzyme in question.37,43 Though not as complex, the coordination of Mg+2 in sugar 
NTs is similar to the octahedral coordination site of Mn+2 seen in GT-As, where the active 
site analysis shows two of the coordinating atoms to Mn+2 are oxygens from the a- and |3-
phosphates and three to four coordination sites are direct interactions to the enzyme.44,46"48,50" 
54 A well defined metal coordination site in GT-As allows for a high degree of coordination 
to occur between the metal, Mn+2, and the protein indicates the presence of a permanent 
binding site.48 This analysis coupled with the fact of a low intracellular concentration of 
Mn+2 (10 nM)33 the presence of a permanent metal binding site seems appropriate. The 
enzymes that constitute GT-Bs, which are not metal dependant, have positively charged 
amino acid residues, four arginines, which are able to form hydrogen bonds directly to the 
phosphates.55"62 
Our findings of no manganese-phosphate complex formation at physiological manganese ion 
concentration fits previously reported crystal structure determinations demonstrating the 
presence of a permanent binding site in GT-As for manganese.48 For highest activity at low 
manganese concentration, the enzyme would need to have a way to permanently sequester 
manganese for full biocatalytic function. However for sugar NTs, which are magnesium 
dependant, the need for a permanent binding site is not required due to the much higher 
physiological concentration of divalent magnesium. As for inhibitors of sugar NTs free UTP 
has been shown to be an inhibitor of Mg-UTP,63 and explains why UDP is an inhibitor in the 
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presence of Mg+2 while it was found not to bind to the enzyme in the absence of a divalent 
metal.63 
The role magnesium plays in the formation of metal-phosphate complexes may shed light in 
why magnesium chloride therapy has lead to a decrease in serum glucose levels in patients 
with type 2 diabetes.15"18 With the increase of the serum Mg+2 concentration there will be an 
increase in the formation of magnesium-phosphate complexes. The complexes formed play a 
critical role by activating the biocatalysts involved in the manner in which glucose is 
biochemically stored and released. The decrease in biocatalyst function would not allow for 
the biochemical pathway to function properly, adequately sequestering glucose as glycogen 
when glucose levels are high and degrading glycogen when glucose levels are low. 
Knowledge of the method in which the metal binds to the substrate can also play an 
important role in drug design. When contemplating inhibitor design for sugar NTs, one must 
design the inhibitor so that it is able to compete against the most prevalent form of the 
substrate, which for this class of enzymes is the NTP-Mg+2 complex. While designing 
inhibitors for glycosyltransferases, one needs to account for the binding that occurs between 
the manganese and the substrate because manganese is likely to be permanently bound in the 
active site and important in the catalytic activity of GT-As while not being important for the 
catalytic activity of GT-Bs. This knowledge may provide a key understanding and aid in the 
development of drug candidates that are able to selectively inhibit one class of 
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glycosyltransferases and phosphorylases over another and that may lead to diabetic drug 
development.20"23 
Materials and Methods 
General material and methods. 2- [4-(2-hydroxyethyl)-1 -piperazinyl] -ethanesulfonic acid 
(Hepes), tetrasodium pyrophosphate decahydrate, magnesium chloride, and manganese (II) 
chloride were all purchased from Fischer Scientific Company (Hanover Park, IL). All other 
compounds were purchased from Sigma Chemical Co. (St. Louis, MO) unless otherwise 
noted and used without further purification. Nanopure water (18.1 MHz) prepared from a 
Barnstead E-pure water purification system was employed throughout. 
Isothermal Titration Calorimetry. ITC experiments were performed on a Microcal VP-ITC 
micorcalorimeter (Northampton, MA), which was calibrated using the built-in electrical 
calibration check. All ITC experiments were conducted in 100 mM Hepes buffer pH 7.5 at 
37 °C. Nucleotide phosphate concentration was determined spectrophotometrically as 
described by Herrero et al} from UV absorbance measurements at 262 nm using an 
extinction coefficient of £202 = 20,000 cm"1 M"1.64 Glucose-1 -phosphate concentrations were 
determined via electrospray ionization mass spectrometry (ESI-MS).65 All solutions were 
degassed, via applied vacuum, immediately prior to use. Titrant solution (2.5, 7.5, or 10 jjL) 
was added from a 300 pL microsyringe at an interval of 200 sec. into the stirred sample cell 
(1.4288 mL) containing the nucleotide phosphate at a stirring rate of 480 rpm. To correct for 
heats of dilution, control experiments were performed by making identical injections of the 
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titrant solution into a cell containing only buffer and these values were subtracted from the 
titration of the titrant solution into the reaction cell. The titrant solution contained the metal, 
Mg+2 or Mn+2 (75 mM), in Hepes buffer (100 mM, pH 7.5). The reaction cell contained 2.5 -
7.5 mM substrate (UTP, UDP, UMP, UDP-Glc, Glc-l-P, or PP,) in Hepes buffer (100 mM, 
pH 7.5). Data (Figure 2.5) was analyzed using nonlinear least-squares curve fitting in Origin 
(7.0, OriginLab Corp., Northampton, MA) using the standard one binding site model 
supplied by Origin. This analysis yielded the thermodynamic parameters K (binding 
constant), enthalpy of binding (AH), entropy of binding (AS), and n, where n is the ratio of 
the metal ion to the substrate in the complex. 
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Figure 2.5. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgClz (syringe) into 2.1 mM UTP (cell) in 100 mM HEPES at pH 7.5 and 37 °C. 
Additional Information. Tables containing all binding parameters for the binding of Mg+2 and 
Mn+2 to phosphates as well as all isothermal titration calorimetry plots are found in the 
appendix at the end of this chapter. 
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Appendix 
Table 2.1. Thermodynamic values for the binding of Mg+2 and Mn+2 to phosphates at 310 K. 
Metal3 Substrate n 
K 
(M'1) 
AG 
(cal/mol) 
AH 
(cal/mol) 
AS 
(cal/mol T) 
Mg+2 UTP 0.991 ± 0.005 14,300 ± 700 -5878 3730 ±30 31.0 
Mg+2 UDP 0.990 ±0.004 3170 ±70 -4952 3480 ±20 27.2 
Mg+2 UMP 1.07 ±0.07 270 ± 9 -3430 570 ± 10 12.9 
Mg+2 UDP-Glc 0.99 ±0.05 250 ± 20 -3399 510 ±40 12.6 
Mg+2 Glc-l-P 0.96 ± 0.02 185 ±4 -3206 1040 ±20 13.7 
Mg+2 PPz 1.030 ±0.006 41,000 ±2000 -6539 -1770 ±10 15.4 
Mn+2 UTP 1.02 ±0.02 13,000 ±2000 -5829 2390 ±60 26.5 
Mn+2 UDP 0.998 ± 0.008 2800 ± 2 -4885 2930 ± 30 25.2 
Mn+2 UMP 1.01 ±0.03 300 ±8 -3507 1640 ±30 16.6 
Mn+2 UDP-Glc 1.00 ±0.04 169 ±8 -3165 1550 ±80 15.2 
Mn+2 Glc-l-P 1.02 ±0.01 340 ±7 -3575 1760 ±20 17.2 
Mn+2 PPz 1.02 ±0.006 288,000 ± 2,200 -7747 -5614 ±80 6.9 
"Ratio of Metal to Substrate (ri), binding constant (K), free energy (AG) as calculated from 
the free energy relationship AG - AH - TAS, enthalpy of binding (AH), and entropy of 
binding (AS). 
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Table 2.2. Percentage of phosphates bound to Mg+2 and Mn+2 when the concentration of 
Mg+2 and Mn+2 is 1.5 mM and 10 nM respectfully at 310 K. 
Metal Substrate % Bounda 
Mg+2 UTP 96 
Mg+2 UDP 83 
Mg+2 UMP 29 
Mg+2 UDP-Glc 27 
Mg+2 Glc-l-P 22 
Mg+2 PPz 98 
Mn+2 UTP 0 
Mn+2 UDP 0 
Mn+2 UMP 0 
Mn+2 UDP-Glc 0 
Mn+2 Glc-l-P 0 
Mn+2 PPz 0 
^Percentage free uridine phosphate as determined form the binding constant, K. 
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Figure 2.6. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgCla (syringe, 60 - 2.5 j-iL injections) into 2.1 mM UTP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
Time (min) 
0 50 100 150 
25-
20 
O 15 
5 
0 
4 T 
Molar Ratio 
Figure 2.7. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgClz (syringe, 120 - 2.5 |iL injections) into 2.8 mM UDP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
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Figure 2.8. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgCli (syringe, 120 - 2.5 |o.L injections) into 4.5 mM UMP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
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Figure 2.9. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgCli (syringe, 40 - 7.5 |xL injections) into 5.6 mM UDP-Glc (cell) in 100 mM HEPES 
at pH 7.5 and 37 °C. 
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Figure 2.10. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MgCli (syringe, 120 - 2.5 |-iL injections) into 5.1 mM a-D-glucose-1-phosphate (cell) in 
100 mM HEPES at pH 7.5 and 37 °C. 
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Figure 2.11. Thermogram (top) and binding isotherm (bottom) showing the addition of 4.5 
mM MgClz (syringe, 120 - 2.5 |_iL injections) into 0.5 mM pyrophosphate (cell) in 100 mM 
HEPES at pH 7.5 and 37 °C. 
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Figure 2.12. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MnClz (syringe, 60 - 2.5 jjL injections) into 2.5 mM UTP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
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Figure 2.13. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MnCla (syringe, 120-2.5 fiL injections) into 7.5 mM UDP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
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Figure 2.14. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MnCli (syringe, 120 - 2.5 |J,L injections) into 4.9 mM UMP (cell) in 100 mM HEPES at 
pH 7.5 and 37 °C. 
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Figure 2.15. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MnClz (syringe, 40 - 7.5 faL injections) into 4.7 mM UDP-Glc (cell) in 100 mM HEPES 
atpH 7.5 and 37 °C. 
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Figure 2.16. Thermogram (top) and binding isotherm (bottom) showing the addition of 75 
mM MnCl2 (syringe, 120-2.5 |j,L injections) into 5.5 mM a-D-glucose-1-phosphate (cell) in 
100 mM HEPES at pH 7.5 and 37 °C. 
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Figure 2.17. Thermogram (top) and binding isotherm (bottom) showing the addition of 4.5 
mM MnCla (syringe, 30 - 10 p,L injections) into 0.5 mM pyrophosphate (cell) in 100 mM 
HEPES at pH 7.5 and 37 °C. 
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CHAPTER 3. General Assay for Sugar Nucleotidyltransferases 
Using Electrospray Ionization Mass Spectrometry 
A paper published in Analytical Biochemistry1 
Corbin J. Zea2,3 and Nicola L. Pohl2'4 
Abstract 
An electrospray ionization mass spectrometry (ESI-MS)-based assay has been developed to 
study the class of enzymes called sugar nucleotidyltransferases that couple sugar-1-
phosphates and nucleotide triphosphates to form Leloir pathway glycosyl donors. The 
recombinant Escherichia coli and the commercially available yeast uridine-diphosphoglucose 
pyrophosphorylases were used as model systems. This technique allows the simultaneous and 
direct detection of the substrates and products without separation and, as described, is as 
sensitive as traditional coupled techniques. More importantly, the assay is capable of easily 
measuring kinetic values and inhibition constants for a range of natural and nonnatural 
substrates. This new assay was used to show for the first time that the reaction of the 
commercially available yeast UDP-glucose pyrophosphorylase preparation is competitively 
inhibited by ATP, an observation that indicates a single active site that accepts both UTP and 
ATP substrates. 
1 Reproduced with permission of Anal. Biochem. (2004), 328, 196-202. Copyright 2004 
Elsevier. 
2 Graduate student and Assistant Professor, respectively, Department of Chemistry and the 
Plant Sciences Institute, Iowa State University 
3 Primary researcher and an author 
4 Author for correspondence 
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Introduction 
The activated glycosyl donors that are required by hundreds of different glycosyltransferases 
are biosynthesized by a class of enzymes called sugar nucleotidyltransferases. These 
enzymes catalyze the formation of nucleotide diphosphosugars from sugar-1-phosphates and 
nucleotide triphosphates. This process is crucial for carbohydrate biosynthesis1"4 and 
therefore these enzymes have been proposed as targets for antibiotic design.5"7 In addition, 
sugar nucleotidyltransferases are vital in the development of chemoenzymatic synthesis 
strategies and are the subject of numerous efforts to test and expand their substrate 
tolerances.8,9 These efforts are impeded, however, as current assays for these enzymes are not 
readily amenable to nonnatural substrates or rapid inhibitor screening. Herein we report the 
first general assay for this class of enzymes that circumvents these difficulties using 
electrospray ionization mass spectrometry. 
The sugar nucleotidyltransferase uridine-5 ' -diphosphoglucose pyrophosphorylase is central 
to primary metabolism and serves as a good model system for this class of enzymes. This 
pyrophosphorylase couples uridine triphosphate (UTP) and glucose-1-phosphate (Glc-l-P) to 
form uridine diphosphate glucose (UDP-glucose), a glucosyl donor that is used in numerous 
biosynthetic pathways, Figure 3.1. Assays for this enzyme involve the use of coupled enzyme 
assays,10"12 radioactively labeled compounds,13,14 or HPLC separation.8'9'14 Traditional 
coupled assays include the UDP-glucose dehydrogenase10 and the 
phosphoglucomutase/glucose-6-phosphate dehydrogenase10 systems. Recently, other coupled 
assay systems11,12 have been developed with improved sensitivities or system capabilities, but 
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Figure 3.1. Reaction scheme for the sugar nucleotidyltransferases that couple sugar-1-
phosphates and nucleotide triphosphates to form Leloir pathway glycosyl donors. 
these require either the expression and purification of numerous enzymes that are not 
commercially available or the monitoring of the reaction in the degradation rather than 
coupling direction. Most coupled assays also directly detect the formation or consumption of 
the product such that only the natural glucose-based substrates can be used. This limitation 
creates problems for enzyme analysis with nonnatural substrates. In addition, since these 
coupled assays are not amenable to the study of sugar nucleotidyltransferases that activate 
other sugars such as galactose and mannose it is essential to have multiple assays for multiple 
sugar-nucleotide systems. The indirect readout using additional enzymes that act on glucose 
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complicate the screening of carbohydrate-like inhibitors, too. A method to circumvent the use 
of additional enzymes is to use radioactively labeled compounds and separation techniques to 
monitor reaction progress. However, the use of this assay for commercially unavailable 
substrates requires the expensive synthesis of radioactive compounds. The separation and 
quantification of products by HPLC permits the use of a range of substrates, but a new 
separation protocol must be developed for each new substrate and HPLC runs themselves are 
so time-consuming as to severely limit high throughput screening of substrates and the 
determination of kinetic parameters. 
Electrospray mass spectrometry is becoming more prevalent as a technique in the study of 
enzyme kinetics.15"26 This approach to enzyme-substrate characterization is particularly 
advantageous because the conventional approach requires compounds that are radioactively 
or chromatogenically labeled.18 Although radioactively labeled compounds are commonly 
used for enzymatic determination, they are expensive, many unusual substrates are not easily 
available which requires their synthesis, and their use creates hazardous waste. Many 
naturally occurring substrates do not contain a functional group that can be monitored 
through traditional spectroscopic techniques. This leads to the attachment of chromatogenic 
ligands that could pose a threat to accurately quantifying the enzyme reaction of question. 
Mass spectrometry circumvents these issues and, fortunately, mass spectrometers are 
becoming more widespread in academia and industry as the instruments become smaller, less 
expensive, and more robust. However, efficient and reproducible substrate ionization 
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protocols that are compatible with particular enzymatic reaction conditions must be 
discovered. 
Results 
A general assay for the coupling of a sugar-1 -phosphate and nucleotide triphosphate requires 
the detection and quantification of either of the two substrates or the product. ESI-MS is 
useful in the analysis of highly charged species in aqueous environments and therefore 
particularly amenable to the study of many enzymatic processes.15"20,24"26 ESI-MS allows this 
detection and quantification of all species simultaneously and without prior separations 
protocols. The requirement of only small sample sizes and the potential for autosampling 
renders this technique ideal for scaling to high throughput. The yeast and Escherichia coli 
UDP-glucose pyrophosphorylases were chosen as models for sugar nucleotidyltransferases in 
our new assay development to demonstrate the ESI-MS-based assay with a variety of 
nucleotides. The E. coli enzyme is known to accept both uridine triphosphate (UTP) and 
deoxythymidine triphosphate (dTTP) as substrates to form activated glycosyl donors;13 
therefore, this enzyme was cloned from genomic DNA and expressed in active form for these 
studies. The commercially available yeast enzyme preparation can turnover not only UTP but 
also to a lesser extent ATP; it is not clear, however, if the dual activity derives from one 
enzyme active site, a bifunctional enzyme, or contaminating enzymes. Assay conditions for 
inhibition kinetics that can measure if or how ATP competes for UTP in this yeast enzymatic 
reaction could resolve this issue in addition to showing the potential of this assay to screen 
other inhibitors. 
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The development of conditions that allow reproducible efficient analyte ionization is crucial 
for the success of an ESI-MS-based assay. We discovered that the use of triethylamine in the 
quench buffer increased the substrate ionization and decreased the percentage of sodium ion 
adducts such that multiple ion peaks did not have to be monitored. Desalting of the 
commercially available yeast enzyme also increased the substrate ionization efficiencies and 
led to greater reproducibility. Finally, the use of an inline C-18 column also reduced the 
percentage of sodium ion adducts by 10-15%. However, the ESI-MS analysis of the reaction 
samples was accomplished without the separation of reaction components. Under these 
conditions, large differences in product ionization efficiencies for various NDP-sugars were 
not seen, Figure 3.2. 
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Figure 3.2. Calibration curves for the relative intensity of UDP-glucose (•), ADP-glucose 
(o), and dTDP-glucose (•) as compared to AMP (R2=0.99). There was no noticeable 
difference between NDP-glucose in Tris buffer (25 mM) at pH 7.6 or 7.8. 
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Method Comparison. To validate the ESI-MS technique, we determined the amount of UDP-
glucose formed via the ESI-MS technique and the UDP-glucose dehydrogenase coupled 
assay as outlined by Kamogawa and Kurahashi.10 The enzyme reaction run in the direction of 
UDP-glucose production and in the presence of the yeast UDP-glucose pyrophosphorylase 
was run in triplicate and each sample divided in two and analyzed via both assays for the 
final UDP-glucose concentration. Using the ESI-MS technique the amount of UDP-glucose 
formed, as determined by monitoring the m/z of 565, was determined to be 1.7 ± 0.2 mM, 
while the same samples using the UDP-glucose dehydrogenase coupled assay, as determined 
by monitoring the formation of NADH at 340 nm, was determined to be 1.5 ± 0.1 mM. These 
two values are in good agreement and the comparison helps to validate the ESI-MS 
technique. 
KM and Vmax. The appearance of the product UDP-glucose could be monitored by ESI-MS 
and its concentration accurately determined. Although the sugar-1 -phosphate and nucleotide 
triphosphate ions could also be monitored for their disappearance during the reaction course 
by ESI-MS, previous reactions have monitored product formation in determining kinetic 
parameters and therefore this same tact was taken to compare methods. To determine the 
kinetic parameters for the UDP-glucose pyrophosphorylase reactions from E. coli and yeast, 
the concentration of glucose-1 -phosphate (2-100 |iM) was varied at constant nucleotide 
triphosphate concentrations (300 (j,M). Standard enzymatic analysis, a Michaelis-Menten plot 
of the velocity versus glucose-1-phosphate ion concentration could be determined using the 
ESI-MS technique for yeast in the presence of UTP and ATP (Figure 3.3) and E. coli in the 
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presence of UTP and dTTP (Figure 3.4). The enzymatic reactions were run in triplicate with 
the error bars representing the standard deviation from the mean of three averaged data 
0 25 50 75 100 
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Figure 3.3. Michealis-Menten plots for yeast UDP-glucose pyrophosphorylase in the 
direction of NDP-glucose synthesis for UTP (•) and ATP (•). 
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Figure 3.4. Michealis-Menten plots for E. coli UDP-glucose pyrophosphorylase in the 
direction of NDP-glucose synthesis for UTP (•) and dTTP (•). 
points. Nonlinear regression of the data yield the kinetic values for the yeast enzyme and 
UTP to have values for KM and Vmax to be 7 ± 1 and 3.8 ± 0.1 jaM/min respectively and 
with ATP to have values for KM and Vmax to be 7 ± 1 |iM and 1.67 ± 0.07 pM/min 
respectively. The kinetic values for the E. coli enzyme and UTP to have values for Km and 
Vmax to be 12 ± 2 [J.M and 1.15 ± 0.06 |-iM/min respectively and with dTTP to have values 
forÀM and Vmax to be 13 ± 2 JJ.M and 0.90 ± 0.05 jaM/min respectively (Table 3.1). The KM 
value for the E. coli enzyme compares well to the previously reported values of 48 p.M10 and 
10 [M.13 
Substrates KM (pM) Vmax ((iM/min) 
yeast UTP - Glc-l-P 7 ± 1 3.8 ±0.1 
ATP-Glc-l-P 7 ± 1 1.67 ±0.07 
E. coli UTP - Glc-l-P 1 2  ± 2  1.15 ±0.06 
dTTP - Glc-l-P 1 3  ± 2  0.90 ± 0.05 
Table 3.1. Kinetic values of Glc-l-P for the synthesis of NTP-glucose by UDP-glucose 
pyrophosphorylase from yeast and E. coli. 
Inhibition Studies. Because yeast UDP-glucose pyrophosphorylase has previously been 
shown to accept both UTP and ATP as substrates11 the determination whether the source of 
this unique activity was from an impure enzyme prep, an enzyme with multiple active sites, 
or a Afunctional single site enzyme, we set out to determine if ATP is an inhibitor of UTP 
for this enzyme. The ESI-MS assay was tested in the presence of ATP to determine if this 
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technique is amenable to enzyme inhibition studies. The velocity was determined at various 
ATP concentrations (0, 50, 100 |o,M) by measuring the amount of UDP-glucose formed in 5 
minutes at various UTP concentrations (40, 70, 100, 150, 250, 500 The resulting double 
reciprocal plot (Figure 3.5) shows the linear regression lines intersecting at the y-axis, 
indicating that ATP is a competitive inhibitor with respect to UTP. This result implies that 
ATP can compete with UTP in the active site of the yeast UDP-glucose pyrophosphorylase; 
the enzyme has a bifunctional active site. 
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Figure 3.5. Double reciprocal plot of 1/Velocity vs. 1/[UTP] for yeast UDP-glucose 
pyrophosphorylase at different ATP concentrations: 0 pM ATP (•), 50 |uM ATP (•), 100 fiM 
ATP (o) when [UTP] = 40, 70, 100, 150, 250, 500 pM. 
Conclusion 
An ESI-MS based assay has been developed to study the class of enzymes that couple 
sugar-1-phosphates and nucleotide triphosphates to form Leloir pathway glycosyl donors. 
This technique allows the simultaneous and direct detection of the substrates and products 
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without separation and, as described, is as sensitive as traditional coupled techniques. The 
assay also is capable of easily assaying a range of natural and nonnatural substrates to 
determine the substrate binding parameters of a range of sugar nucleotidyltransferases. In 
contrast to traditional coupled techniques, this technique does not need to be concerned with 
the impact an inhibitor may have on the analytical method. With 96-well and 384-well plate 
autosamplers, the ESI-MS-based assay is also amenable for the high throughput screening of 
substrates and inhibitors of sugar nucleotidyltransferases. In addition, this technique has 
shown for the first time that the commercially available yeast UDP-glucose 
pyrophosphorylase preparation is competitively inhibited by ATP and therefore contains a 
Afunctional active site that accepts both UTP and ATP as substrates. The increased sample 
throughput compared to current HPLC methods used for nonnatural substrate evaluation of 
these enzymes now finally opens the doors to kinetic analyses of sugar 
nucleotidyltransferases with a range of substrates to discover the origins of their substrate 
selection as well as to evaluate their potential as antibiotic targets. 
Materials and Methods 
General materials and methods. Trizma base and trizma hydrochloride were purchased from 
Fischer Scientific Company (Hanover Park, IL). Thermostable inorganic pyrophosphatase 
(IPP) from Thermococcus litoralis (EC 3.6.1.1, M0296S) was purchased from New England 
Biolabs as a 2000 U/mL 50% glycerol solution in Tris buffer (pH 8.0). 
Isopropylthiogalactoside (IPTG) was obtained from Labscientific, Livingston, NJ. All other 
chemicals were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise noted 
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and used without further purification. Yeast UDP-glucose pyrophosphorylase (EC 2.7.7.9, 
9026-22-6) was desalted by buffer exchange using Microcon Centrifugal Filter Device, 
MWCO 10 kDa (Millipore, Billerica, MA). Nanopure water (18.1 MHz) prepared from a 
Bamstead E-pure water purification system was employed throughout. Genomic DNA from 
Escherichia coli was obtained from cells using the DNeasy Tissue Kit (Qiagen, Valencia, 
CA). Polymerase chain reactions (PCR) were performed according to Stratagene protocols 
using cloned PfuTurbo Hotstart DNA polymerase (Stratagene, La Jolla, CA) on an 
Eppendorf Mastercycler gradient thermocycler. PCR products were recovered from agarose 
gels using the QIAquick Gel Extraction kit (Qiagen, Valencia, CA). Subcloning into a 
ZeroBlunt vector was achieved using the ZeroBlunt PCR cloning kit (Invitrogen, Carlsbad, 
CA). E. coli BL21(DE3) (Novagen, Madison, WI) was grown in Luria-Bertani (LB) medium 
at 37 °C on an incubator shaker at 225 rpm, supplemented with kanamycin (50 pg/mL, 
Labscientific, Livingston, NJ) when necessary. Oligonucleotides were purchased from 
Operon (Alameda, CA). Restriction endonucleases and ligase were purchased from Promega 
(Madison, WI) or New England Biolabs (Beverly, MA). SOS-PAGE gels (Tris-HCl 10-20% 
gradient, BioRad, Hercules, CA) were stained with colloidal Coomassie blue. Nickel affinity 
spin columns (1.5 mL) were purchased from Qiagen (Valencia, CA, 31314). 
Cloning, Expression, and Purification of UDP-glucose pyrophosphorylase from E. coli. For 
the construction of the E. coli sugar nucleotidyltransferase expression plasmid, Spel and Xhol 
sites were introduced at the translational start codon and just before the translational stop 
codon of the gene, respectively. The forward primer 5'-
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AAAACTA GTatggctgccattaatacgaaagtc-3 ' and the reverse primer 5'-
TTTCrCGA Gttacttcttaatgcccatctcttcttc-3 ' (nucleotides in italics denote the Spel and Xhol 
restriction sites, respectively) were used to amplify the UDP-glucose pyrophosphorylase 
(galU) gene,13 using E. coli genomic DNA as a template. The PCR product was purified by 
1.0% agarose gel electrophoresis and cloned into a ZeroBlunt vector. The resulting construct 
was digested with Xhol and Spel and a pET28a(+) vector was digested with Xhol and Nhel 
and the resulting gel-purified fragments were ligated to create pNLPl 1. The plasmid pNLPl 1 
was introduced into E. coli BL21(DE3) cells by heat-shock transformation and selection for 
kanamycin resistance. For induction of protein expression with cells containing pNLPl 1, 
IPTG was added to a final concentration of 1 mM when the optical density at 600 nm of the 
cell culture reached 0.6-0.8; the culture then was incubated at 37 °C for an additional 4 h. 
Cells were collected by centrifugation (4,600 x g, 4 °C, 10 min) and stored at -80 °C, then 
lysed by sonication (Fisher Model 100 Sonic Dismembranator, Fisher Scientific, Pittsburgh, 
PA). Proteins were purified by metal chelate chromatography by following the recommended 
procedures provided by Qiagen and dialyzed into the reaction buffers using a Microcon 
Centrifugal Filter Device, MWCO 10 kDa (Millipore, Billerica, MA). Protein concentration 
was measured by the method of Bradford,27 using bovine serum albumin as the standard. 
MS Conditions. A Shimadzu LCMS 2010 quadrupole mass spectrometer (Shimadzu 
Scientific Instruments, Columbia, MD) equipped with an electrospray ionization (ESI) source 
was used in negative ion mode. The capillary temperature and the spray voltage were kept at 
220 °C and 4.5 kV, respectively. The instrument was calibrated by direct infusion of 
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polyethylene glycol (PEG) 200, 600, 1000 (1.5 pL/L, 2 pL/L, and 15 pL/L, respectively) and 
raffinose (50 mg/L) in water/methanol (1:1, v:v) containing ammonium acetate (0.19 mM), 
0.1% formic acid, and 0.1% acetonitrile. For sample analysis the solvent 
(acetonitrile/water/triethylamine, 35/65/0.2) was constantly infused into the ion source at 250 
pL/min by the attached Shimadzu HPLC pump and the samples were injected (30 pL) via the 
autosampler adapted to fit two 96-well plates. A preliminary MS chromatogram was obtained 
by scanning from 50 - 700 m/z. To increase the signal to noise ratio, the instrument was set 
for selected ion monitoring (SIM) mode and all relevant m/z ions were monitored for further 
analysis of the enzymatic reactions. Inclusion of an Agilent Extend CI8 column (2.1 x 50 
mm, Agilent, Palo Alto, CA) in the system further increased the signal to noise ratio and 
decreased the appearance of sodium ion adducts by 10-15% without separation of reaction 
components. Postrun software (LCMS Postrun version 2.02, Shimadzu Scientific 
Instruments, Columbia, MD) was used to analyze the data from the ESI-MS chromatogram. 
Peaks were integrated to determine the relative intensity of each ion species monitored as 
compared to an internal standard. 
Enzyme Activity Determination. The enzymatic activity was determined for both the yeast 
and E. coli enzymes by the consumption of glucose-1-phosphate in the direction of UDP-
glucose biosynthesis. The enzymatic reaction was initiated by the addition of glucose-1-
phosphate (10 mM) to a reaction mixture (50 pL) containing Tris buffer (25 mM, pH 7.6 or 
7.8), IPP (0.2 U), UDP-glucose pyrophosphorylase enzyme solution (10 pL), and UTP (10 
mM). Reactions were carried out at 37 °C and after 5 minutes 15 pL of the reaction mixture 
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was quenched by addition to 30 pL of 70% methanol/water containing AMP (3 mM) as an 
internal standard. The quenched solutions were centrifuged 10 minutes at 10,000 x g to 
precipitate the protein. Aliquots (15 pL) of the reaction mixtures were diluted with 135 pL of 
acetonitrile/water/triethylamine (35/65/0.2). These samples (5 pL) were subjected to analysis 
via ESI-MS to determine the amount of glucose-1-phosphate consumed. The amount of 
glucose-1 -phosphate consumed was compared to a blank containing heat killed (95 °C, 5 
min) enzyme. One unit of enzyme is defined as one micromole of glucose-1-phosphate 
consumed per minute. 
Kinetic analysis 
Standard Curves. Calibration curves were run in triplicate containing UDP/ADP/dTDP-
glucose (1 - 20 pM), glucose-1 -phosphate (10 mM), and IPP (0.2 U) in Tris buffer (25 mM, 
pH 7.6 or 7.8) in a final volume of 50 pL. The samples (30 pL) were diluted with 30 pL of 
70% methanol/water containing AMP (6 pM) as an internal standard, then centrifuged and 
diluted as described above. These samples (30 pL) were subjected to analysis via ESI-MS. A 
plot of the resulting relative intensity of UDP/ADP/dTDP-glucose (m/z = 565, 588, and 563) 
as compared to AMP (m/z = 346) was plotted against UDP/ADP/dTDP-glucose 
concentration and was found to fit a straight line (Figure 3.2). 
Method comparison. For the purpose of comparing the ESI-MS-based assay with a known 
protocol, the UDP-glucose dehydrogenase assay, an enzymatic reaction was initiated by the 
addition of glucose-1 -phosphate (10 mM) to a reaction mixture (600 pL final volume) 
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containing Tris buffer (25 mM, pH 7.6), IPP (0.2 U), UDP-glucose pyrophosphorylase 
enzyme from yeast (0.02 U), and UTP (10 mM). Reactions were carried out at 37 °C and 
after 60 minutes the reaction mixture was heated to 95 °C for 1 min. After cooling, 300 pL of 
the reaction mixture was analyzed for the amount of UDP-glucose produced by the use of 
UDP-glucose dehydrogenase as outlined by Kamogawa and Kurahashi.10 Simultaneously, 15 
[iL of the cold reaction mixture was quenched by addition to 30 (iL of 70% methanol/water 
containing AMP (3 mM) as an internal standard, then centrifuged and diluted as described 
above. These samples (5 pL) were subjected to analysis via ESI-MS to determine the amount 
of UDP-glucose produced. 
Measurement of KM and Vmax of Glc-l-P. The values of KM and Vmax were derived from 
enzymatic reactions run in triplicate and determined from the initial rates of 
UDP/ADP/dTTP-glucose formation by monitoring the rate of UDP/ADP/dTDP-glucose 
formation using ESI-MS. The reaction conditions were modified from a previously reported 
procedure.13 The enzymatic reaction was initiated by the addition of glucose-1-phosphate (2 
- 100 pM) to a obtain a reaction mixture containing Tris buffer (25 mM, pH 7.6 or 7.8), IPP 
(0.2 U), UDP-glucose pyrophosphorylase (2 x 10"5 U), and UTP/ATP/dTTP (300 |aM) with a 
final volume of 50 |xL. Reactions were carried out at 37 °C and after 5 minutes 30 \xL of the 
reaction mixture was quenched by addition to 30 pL of 70% methanol/water containing AMP 
or UMP (6 |iM) as an internal standard, then centrifuged and diluted as described above. 
These samples (30 pL) were subjected to analysis via ESI-MS to determine the amount of 
UDP/ADP/dTDP-glucose formed. 
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Inhibition Study. The inhibition of the yeast UDP-glucose pyrophosphorylase enzyme with 
UTP was run in triplicate and was determined from the initial rates of UDP-glucose 
formation using ESI-MS. The enzymatic reaction was initiated by the addition of glucose-1-
phosphate (2 mM) to obtain a reaction mixture containing Tris buffer (25 mM, pH 7.6), IPP 
(0.2 U), UTP (20, 50, 100, 250, and 500 pM) and the inhibitor ATP (0, 50, 100 pM) in a 
final volume of 50 pL. Reactions were carried out at 37 °C and after 5 minutes 30 pL of the 
reaction mixture was quenched by addition to 30 pL of 70% methanol/water containing AMP 
(6 pM) as an internal standard, then centrifuged and diluted as described above. These 
samples (30 pL) were subjected to analysis via ESI-MS to determine the UDP-glucose 
concentration. 
Data Analysis. All kinetic data was fitted with the non-linear regression algorithm in 
GraphPad Prism version 4.0 (GraphPad Software, San Diego, CA). Error bars on the graphs 
represent the standard deviation of three independent averaged data points. 
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CHAPTER 4. Discovery of the Archaeal Chemical Link between Glycogen 
(Starch) Synthase Families Using a New Mass Spectrometry Assay 
A paper published in the Journal of the American Chemical Society1 
Corbin J. Zea,2'3 Stephen W. MacDonell,2 and Nicola L. Pohl2'4 
Abstract 
Starch and its analog glycogen are biosynthesized by enzymes that have been classified by 
sequence similarities into two families that have no significant sequence overlap: the 
animal/fungal glycogen synthases and the plant/bacterial glycogen (starch) synthases. Recent 
gene sequence analysis of putative archaea enzymes implicate them as a third family that 
links the structural and functional features of the other two classes. Herein we present the 
first rapid electrospray ionization mass spectrometry-based assay to quantify any 
carbohydrate-polymerizing activity, the first cloning and recombinant expression as well as 
verification of the putative function of a glycogen synthase from the hyperthermophilic 
archaea Pyrococcus furiosus, and the characterization of a variety of glycogen synthases with 
the new assay. The new assay allowed the determination of KM and Vmax values for the rabbit, 
yeast, and P. furiosus glycogen synthases. Most surprisingly, unlike the synthases from rabbit 
or yeast and in contradiction to what would be expected from structural studies of other 
nucleotide-sugar binding proteins, the synthase from the archaea source accepts both uridine-
and adenine-diphosphate activated glucose competitively and with comparable affinities to 
1 Reproduced with permission of J. Am. Chem. Soc. (2003), 115, 13666-13667. Copyright 
2003 American Chemical Society. 
2 Graduate student, undergraduate student, and Assistant Professor, respectively, Department 
of Chemistry and the Plant Sciences Institute, Iowa State University 
3 Primary researcher and an author 
4 Author for correspondence 
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form a glucose polymer. This loose substrate specificity implicates this protein as the 
chemical link between the two branches of glycogen synthases that have evolved to accept 
primarily one or the other nucleotide as well as a good source enzyme for polymer 
bioengineering efforts. 
Introduction 
The chemical structures of carbohydrate polymers range from homopolymers of glucose such 
as glycogen or cellulose to the complex heteropolymers such as heparin, which serves as an 
anticoagulant.1"3 Many of these polymers, as well as their chemically and physically modified 
variants, are key industrial and medical materials. In particular, starch and its modified 
variants are produced on a 20 million ton scale each year for products that range from paper 
and textile coatings to food additives and pill components.2 Starch and its analog glycogen 
are biosynthesized by enzymes that have been classified by sequence similarities into two 
families that have no significant sequence overlap: the animal/fungal glycogen synthases and 
the plant/bacterial glycogen (starch) synthases.4 Recent gene sequence analysis of putative 
archaea enzymes implicate them as a third family that links the structural and functional 
features of the other two classes.4 Herein we present evidence that an archaea glycogen 
synthase does indeed catalyze the polymerization in a single binding site of both the substrate 
used by the animal/fungal synthases and the substrate used by the plant/bacterial synthase. In 
addition, we describe the first rapid electrospray ionization mass spectrometry-based assay to 
quantify any carbohydrate-polymerizing activity, the first cloning and recombinant 
expression as well as verification of the putative function of a glycogen synthase from the 
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hyperthermophilic archaea Pyrococcus furiosus, and the characterization of several glycogen 
synthases with the new assay. 
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Figure 4.1. Glycogen/starch synthases catalyze the polymerization of glucose from either 
adenine or uridine diphosphate glucose, depending on the organism. A new assay that allows 
monitoring of the disappearance of the starting material by electrospray ionization mass 
spectrometry has enabled the discovery of a glycogen synthase that competitively accepts 
both adenine and uridine nucleotide activated glucose sugars. 
Glycogen synthase activity (Figure 4.1) is usually monitored by the incorporation of 
radioactive glucose-nucleotide diphosphate into the glycogen polymer after separation of the 
starting materials and product.5"8 This method is powerful when repeated monitoring of 
natural substrate turnover is required, but the substrate modifications required become 
cumbersome if a variety of possible alternative substrates are tested. Mass spectrometry 
could allow the direct detection of substrates and/or products without prior purification or the 
use of special chromogenic or radiolabeled components.9"17 
65 
Results 
Assays for carbohydrate-polymerizing enzymes using mass spectrometry should be feasible 
since the nucleotide diphosphate sugar substrates of this class of enzymes are readily 
detectable by electrospray ionization mass spectrometry (ESI-MS) in negative ion mode. To 
quantify this signal, a calibration curve was constructed with various concentrations of the 
activated sugars in the reaction mixture and enzyme assays were run in the concentration 
range where ionization was linear using the commercially available glycogen synthase from 
rabbit muscle. The disappearance of sugar nucleotide was monitored over time to construct a 
Michaelis-Menten curve. Nonlinear regression analysis of reactions run in triplicate resulted 
in a Km = 5.9 ± 0.5 mM and Vmax = 0.340 ± 0.008 mM/min, which compares favorably to the 
previous results from the traditional radioactivity based assay (Km = 0.5 to 48 mM).6,7 
Kinetic values determined by mass spectrometry for the recombinant yeast glycogen 
synthase (Km = 11.4 ± 0.7 mM and Vmax = 0.419 ± 0.009 mM/min or an activity = 28.6 ± 0.6 
pmol/min/mg) also matched those found by the radioactivity-based assay (Km = 2.1 mM and 
activity = 30.2 pmol/min/mg).8 To verify that the substrate was converted into glycogen and 
not simply hydrolyzed, the amount of glycogen formed at the end of the reaction was 
measured using a commercially available coupled assay,18 indicating that the amount of 
glycogen formed was equivalent to the amount of UDP-glucose consumed as determined by 
ESI-MS. Our glycogen synthase assay based on ESI-MS enables detection of submicromolar 
quantities of substrate, thus requiring even lower concentrations of protein, and is amenable 
to high throughput screening methods. 
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Next, the assay was tested with a protein from a putative archaea glycogen synthase gene to 
verify the gene function and test its chemical links to the characterized synthases from plants, 
animals, bacteria, and fungi. The genes from hyperthermophiles also might provide 
thermostable enzymes for synthesis. The recently sequenced thermal vent bacteria P. furiosus 
is of particular interest as a comprehensive structural proteomics effort soon promises a large 
amount of structural information that will need to be correlated to verified chemical function 
data.19 Based on primary sequence homology, the gene believed to be responsible for 
glycogen synthesis in P. furiosus was copied using the polymerase chain reaction and ligated 
into a vector that provides a polyhistidine tag at the C-terminus of the expressed protein for 
ease of purification. Lac repressor-based protein induction in Escherichia coli was started 
using isobutyl-C-galactoside,20 an improved mimic of isopropylthiogalactoside, and the 
expressed protein was purified using a nickel-affinity column. 
To evaluate the function and substrate specificity of this new gene product, the enzyme was 
first tested with UDP-glucose at varying temperature and pH. A mixture without enzyme was 
run to control for background substrate hydrolysis at elevated temperatures. The optimal 
activity was at 80 °C and a pH of 5.0, reaction parameters which are similar to the optimal 
conditions reported for the glycogen synthase from Thermococcus hydrothermalis21 and 
which also would inactivate E. coli proteins that might have coeluted with the P. furiosus 
protein. Nonlinear regression analysis of reactions run in triplicate resulted in a Km = 4.1 ± 
0.4 mM and Vmax = 0.266 ± 0.007 mM/min using UDP-glucose as a substrate. Both the yeast 
and rabbit enzymes have substantially enhanced rates in the presence of glucose-6-phosphate, 
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which acts as a regulator.4,7,22 However, the P. furiosus glycogen synthase shows identical 
kinetics parameters with or without glucose-6-phosphate present. Surprisingly, this 
hyperthermophilic enzyme could also turnover ADP-glucose with comparable speed (Km = 
4.3 ± 0.3 mM and Vmax = 0.307 ± 0.007 mM/min). 
This finding raised the intriguing question as to whether the enzyme had a single binding site 
for such diverse nucleotide substrates or the enzyme was bifunctional with two separate 
binding sites. Two hyperthermophilic glycogen synthases from T. hydro thermal is21 and 
Sulfolobus acidocaldaius23 appear to accept both UDP-glucose and ADP-glucose as 
substrates; however, these enzymes were only partially purified from their natural sources 
and therefore the dual activity possibly could be attributed to protein contaminants. Even if a 
sole enzyme was responsible for the dual activity, no competition studies exist to ascertain if 
the synthase has two separate binding sites for the nucleotides or if a single binding site 
competes for such different nucleotide substrates. The former hypothesis makes most sense 
in light of crystallography studies of several nucleotide-sugar binding proteins that implicate 
the nucleotide diphosphate portion of the sugar-donor for a significant portion of the 
substrate binding contacts to the protein.24"30 To address this question, competition 
experiments were carried out with each nucleotide at various concentrations of the other 
nucleotide in triplicate (Figure 4.2). These results clearly indicate that UDP-glucose and 
ADP-glucose serve as competitive inhibitors of one another with a Kj of 18 ± 6 mM for 
UDP-glucose and 22 ± 2 mM for ADP-glucose. When both substrates are mixed together in 
equal parts, ADP-glucose was consumed at a slightly faster rate than that of UDP-glucose. 
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Conclusion 
This competition evidence is the first clear indicator that archaea enzymes have a binding 
pocket that can accommodate both nucleotide-glucose donors commonly found in cells. 
These hyperthermophilic enzymes then may have lost their ability to bind one or the other 
nucleotide-sugar as they evolved into the two classes of enzymes found in mesophilic 
organisms today that accept either ADP- or UDP-glucose as a polymerization substrate. The 
structural basis of the reduced substrate specificity and the binding requirements of the sugar 
portion of the donor remain open questions. The reported new ESI-MS-based assay, 
however, enables the latter question to be addressed without the synthesis of radioactive 
substrates or development of separation protocols. In addition this work enables the 
screening or discovery of new proteins or protein mutants that can polymerize unusual sugars 
for the biosynthesis of novel carbohydrate polymers. 
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Figure 4.2. Competition experiments for ADP- versus UDP-glucose for the P. furiosus 
glycogen synthase. Double reciprocal plot of (a) 1/V vs. 1/[ADP-glucose] at different UDP-
glucose concentrations: 0 mM (•), 10 mM (•), 20 mM (•); and (b) 1/V vs. 1/[UDP-glucose] 
at different ADP-glucose concentrations: 0 mM (•), 10 mM (•), 20 mM (•). 
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Additional Information: Experimental details for production of the P. furiosus glycogen 
synthase, details of the mass spectrometry assays including calibration curves, and all 
Michaelis-Menten, Lineweaver-Burke, and competition experiment plots are found in the 
Appendix at the end of this chapter. 
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Appendix 
Materials and Methods 
General Methods. The rabbit muscle glycogen synthase (EC 2.4.1.11, 9014-56-6) was 
obtained from Sigma (St. Louis, MO). The yeast glycogen synthase was expressed and 
purified as previously reported.1 Isopropylthiogalactoside (IPTG) was obtained from 
Labscientific (Livingston, NJ). Isobutyl-C-galactoside (IBCG) was synthesized in our lab as 
previously reported.2 All other chemicals were obtained from Sigma (St. Louis, MO) unless 
otherwise noted. Glycogen was purified by precipitation from water (6.8 mg/mL) by two 
volumes of 70% methanol/water. Genomic DNA from Pyrococcus furiosus (ATCC 43587D) 
was obtained from the American Type Culture Collection (Manassas, VA). The polymerase 
chain reaction (PCR) was performed according to Stratagene protocols using cloned 
PfuTurbo Hotstart DNA polymerase (Stratagene, La Jolla, CA) on an Eppendorf 
Mastercycler gradient thermocycler. E. coli BL21(DE3) Codon Plus cells (Novagen, 
Madison, WI) were grown in Luria-Bertani (LB, Sigma, St. Louis, MO) medium at 37°C on 
an incubator shaker at 225 rpm, supplemented with carbenicillin (100 jig/mL, Labscientific, 
Livingston, NJ) when necessary. Oligonucleotides were purchased from Operon (Alameda, 
CA). Restriction endonucleases and ligase were purchased from Promega (Madison, WI) or 
New England Biolabs (Beverly, MA). SDS-PAGE gels (Tris 10-20% gradient, BioRad, 
Hercules, CA) were stained with colloidal Coomassie blue (Sigma, St. Louis, MO). 
Cloning, Expression, and Purification of Hyperthermophilic Glycogen Synthase. For the 
construction of the P. furiosus glycogen synthase expression plasmid, Ndel and Xhol sites 
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were introduced at the transnational start codon and just before the transnational stop codon of 
the gene, respectively. The forward primer 5 '-AAACCA Ta/gaaggtacttttgcttggc-3 ' and the 
reverse primer 5 ' -AAAGCGGCCGCaactccggtgctgatgaagtc-3 ' (nucleotides in italics denote 
the Ndel and NotI restriction sites, respectively) were used to amplify the putative glycogen 
synthase gene using P. furiosus genomic DNA (ATCC 43587D) as a template. The PGR 
product was purified by 1.0% agarose gel electrophoresis and recovered from an agarose gel 
using the QIAquick Gel Extraction kit (Qiagen, Valencia, CA) before subcloning into a 
ZeroBlunt vector using the ZeroBlunt PGR cloning kit (Invitrogen, Carlsbad, CA). The 
resulting construct was digested with Ndel and NotI as was a pET21a vector containing a C-
terminal histidine-tag sequence (Novagen, Madison, WI) and the resulting gel-purified 
fragments were ligated to create the expression plasmid. This plasmid was introduced into E. 
coli BL21(DE3) Codon Plus cells by heat-shock transformation and selection for 
carbenicillin resistance. 
For induction of protein expression, IPTG (ImM) or IBCG (0.5 mM) was added when the 
optical density at 600 nm of the cell culture reached 0.6-0.8 and the culture was incubated at 
37 °C for an additional 4 hr. Cells were collected by centrifugation (3600 x g, 25 °C, 10 
min), decanted, and stored at -80 °C. The frozen cell pellet was lysed by sonication (Fisher 
Model 100 Sonic Dismembranator, Fisher Scientific, Pittsburgh, PA) and the proteins were 
purified by metal chelate chromatography by following the recommended procedures 
provided by Novagen and dialyzed into the reaction buffers using a Microcon Centrifugal 
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Filter Device, MWCO 10,000 Da (Millipore, Billerica, MA). Protein concentration was 
measured by the method of Bradford,3 using bovine serum albumin as the standard. 
Mass Spectrometry Assays. A Shimadzu LCMS 2010 quadrupole mass spectrometer 
(Shimadzu Scientific Instruments, Columbia, MD) equipped with an ESI source was used in 
negative ion mode. The capillary temperature and the spray voltage were kept at 220 °C and 
4.5 kV, respectively. The instrument was calibrated by direct infusion of polyethylene glycol 
(PEG) 200, 600, 1000 (1.5 jllL/L, 2 pL/L, and 15 (.iL/L, respectively) and raffinose (50 mg/L) 
in water/methanol (1:1, v:v) containing ammonium acetate (0.19 mM), 0.1% formic acid, and 
0.1% acetonitrile. For sample analysis the solvent (acetonitrile/water/triethylamine, 
35/65/0.2) was constantly infused into the ion source at 250 p,L/min by the attached 
Shimadzu HPLC pump and the samples were injected (5 jj,L) via the autosampler adapted to 
fit two 96-well plates. A preliminary MS chromatogram was obtained by scanning from 50 -
700 m/z. To increase the signal to noise ratio, the instrument was set for selected ion 
monitoring (SIM) mode and all relevant m/z ions were monitored for further analysis of the 
enzymatic reactions. Inclusion of an Agilent Extend CI 8 column (2.1 x 50 mm, Agilent, Palo 
Alto, CA) in the system further increased the signal to noise ratio and decreased the 
appearance of sodium ion adducts by 10-15% without separation of reaction components. 
Postrun software (LCMS Postrun version 2.02, Shimadzu Scientific Instruments, Columbia, 
MD) was used to analyze the data from the ESI-MS chromatogram. Peaks were integrated to 
determine the relative intensity of each ion species monitored as compared to an internal 
standard. 
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Calibration curves of the relative intensity of the substrate (UDP-glucose or ADP-glucose) to 
the internal standard (AMP or UMP) were constructed over the concentration range of 0.5 -
25 mM. The measured concentrations of UDP-glucose and ADP-glucose fell within this 
range. 
Enzyme Reaction Conditions. Each enzymatic reaction was run in triplicate and contained 
e i t h e r  T r i s  o r  a c e t a t e  b u f f e r  ( 5 0  m M )  a t  t h e  a p p r o p r i a t e  p H ,  0 . 0 2  U n i t s  o f  e n z y m e ,  2 - 1 0 0  
mM UDP-glucose or ADP-glucose, 6.8 mg/mL glycogen, and 7.2 mM glucose-6-phosphate 
(G-6-P) when used. The enzymatic reactions were allowed to incubate for 10 minutes at the 
desired temperature before the addition of UDP-glucose or ADP-glucose. Non-enzymatic 
degradation of UDP-glucose and ADP-glucose was accounted for by subtracting a blank, 
which did not contain enzyme, from the enzymatic reaction. When the substrate 
concentration was 2-25 mM the reaction was quenched after 20 minutes by the addition of 15 
pL of the reaction mixture to 30 jaL of 70% methanol/water containing UMP (3 mM, when 
ADP-glucose is the substrate) or AMP (3 mM, when UDP-glucose is the substrate) as an 
internal standard. At higher substrate concentrations (50, 75, or 100 mM) the reaction was 
quenched by the addition of 15 pL of the reaction mixture to 120 p,L of 70% methanol/water 
containing the internal standard. This four fold dilution was necessary to bring the 
concentration of the substrate within range of the internal standard. The quenched solutions 
were centrifuged 10 minutes at 10,000 x g to precipitate the glycogen and protein. Aliquots 
(15 fxL) of the reaction mixtures were diluted with 135 p,L of acetonitrile/water/triethylamine 
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(35/65/0.2). These samples (5 pL) were subjected to analysis via ESI-MS to determine the 
UDP-glucose or ADP-glucose concentration. Determination of the kinetic values by the 
appearance of UDP or ADP was comparable to values obtained by the disappearance of 
UDP-glucose or ADP-glucose when studying the commercial rabbit muscle glycogen 
synthase. However when studying recombinant glycogen synthases from yeast and P. 
furiosus, the data determined from monitoring the disappearance of UDP-glucose and ADP-
glucose was found to be more reliable. 
Activity Determination. The activity of the purified yeast and P. furiosus glycogen synthases 
were determined by measuring how much UDP-glucose was consumed in 8 min. as 
determined by ESI-MS. One unit of enzyme is the amount of enzyme needed to convert 1 
pmol of UDP-glucose to glycogen per minute. 
Optimal Activity Determination of P. furiosus. The pH for optimal activity for the P. furiosus 
glycogen synthase enzyme was measured at 85°C between pH 4.0 and pH 9.0 using 50 mM 
acetate, phosphate, and Tris-HCl buffers. The optimal temperature was measured at pH 5.0 
between 50 °C and 100 °C. 
Inhibition Study. The inhibition of the P. furiosus glycogen synthase enzyme with ADP-
glucose or UDP-glucose was run in triplicate and was determined from the initial rates of 
glycogen elongation by monitoring the rate of UDP-glucose or ADP-glucose degradation 
using ESI-MS. The enzymatic reaction was run in acetate buffer (25 mM, pH 5.0), 0.02 Units 
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of enzyme, 2-50 mM UDP-glucose or ADP-glucose, 0, 10, or 20 mM ADP-glucose or 
UDP-glucose, 6.8 mg/mL glycogen, and 7 mM glucose-6-phosphate. The enzymatic 
reactions were allowed to incubate for 10 minutes at the 80°C before the addition of UDP-
glucose or ADP-glucose. When the substrate concentration is 2-25 mM the reaction was 
quenched after 20 minutes by the addition of 15 |uL of the reaction mixture to 30 pL of 70% 
methanol/water containing UMP (3 mM, when ADP-glucose is the substrate) or AMP (3 
mM, when UDP-glucose is the substrate) as an internal standard. At higher substrate 
concentrations (50, 75, or 100 mM) the reaction was quenched by the addition of 15 jjJL of 
the reaction mixture to 120 \iL of 70% methanol/water containing the internal standard. This 
four fold dilution was necessary to bring the concentration of the substrate within range of 
the internal standard. The quenched solutions were centrifuged 10 minutes at 10,000 x g to 
precipitate the glycogen and protein. Aliquots (15 jiL) of the reaction mixtures were diluted 
with 135 \xL of acetonitrile/water/triethylamine (35/65/0.2). These samples (5 |uL) were 
subjected to analysis via ESI-MS to determine the UDP-glucose or ADP-glucose 
concentration. 
Glycogen Elongation Study. To test for glycogen chain elongation the glycogen synthase 
reaction as described previously was set up for each enzyme source and substrate. The 
reaction was initiated by the addition of UDP-glucose or ADP-glucose and quenched after 30 
min by the addition of 50 pL of the reaction mixture to 100 jaL of 70% methanol/water. The 
quenched solutions were centrifuged 10 minutes at 10,000 x g to precipitate the glycogen. 
The glycogen pellet was rinsed twice with methanol (100 pL) to remove residual glucose-6-
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phosphate and resuspended in 1 mL of water. This sample was analyzed for glycogen content 
using a starch assay kit (SA-20, Sigma, St. Louis, MO). 
Figure 4.3. Protein gel for the purification of glycogen synthase from P. furiosus induced 
with 0.5 mM IBCG, lane 1 : molecular weight marker (113 kDa; 91 kDa; 49.9 kDa; 35.1 kDa; 
28.4 kDa; 20.8 kDa), lane 2: pass, lane 3: 1st wash, lane 4: 2nd wash, lane 5: 3rd wash, lane 6: 
elution, lane 7: molecular weight marker, lane 8: pellet (insoluble fraction). 
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Figure 4.4. Calibration curves of ADP-glucose with G-6-P at pH 5.0 (•), UDP-glucose with 
G-6-P at pH 5.0 (o), UDP-glucose with G-6-P at pH 7.5 (•), UDP-glucose without G-6-P at 
pH 5.0 (•) ,  and UDP-glucose with G-6-P at  pH 7.8 (A).  
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Figure 4.5. Michealis-Menten and Lineweaver-Burke (inset) plot for yeast glycogen 
synthase. 
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Figure 4.6. Michealis-Menten and Lineweaver-Burke (inset) plot for rabbit muscle glycogen 
synthase. 
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Figure 4.7. Michealis-Menten and Lineweaver-Burke (inset) plot for P. furiosus glycogen 
synthase and UDP-glucose with G-6-P (•), and without G-6-P (o). 
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Figure 4.8. Michealis-Menten and Lineweaver-Burke (inset) plot for P. furiosus glycogen 
synthase with ADP-glucose and G-6-P. 
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Figure 4.9. Double reciprocal plot of 1/V vs. 1/[ADP-glucose] for the P. furiosus enzyme at 
different UDP-glucose concentrations: 0 mM (•), 10 mM (o), 20 mM (•) ([ADP-glucose] = 
2, 4, 8,10,15, 25, and 50 mM). 
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Figure 4.10. Double reciprocal plot of 1/V vs. 1/[UDP-glucose] for the P. furiosus enzyme at 
different ADP-glucose concentrations: 0 mM (•), 10 mM (o), 20 mM (•) ([UDP-glucose] = 
2, 4, 8,10,15, 25, and 50 mM). 
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CHAPTER 5. Kinetic and Substrate Binding Analysis of Phosphorylase b 
Via Electrospray Ionization Mass Spectrometry: A Model for Chemical 
Proteomics of Sugar Phosphorylases 
A paper published in Analytical Biochemistry1 
Corbin J. Zea2'3 and Nicola L. Pohl2,4 
Abstract 
As a general strategy for determining the chemical function of the class of enzymes that 
cleaves glycosidic linkages with phosphate, the first mass spectrometry and direct detection 
assay for sugar phosphorylases has been developed and used to study the inhibition and 
minimal binding requirements of rabbit muscle phosphorylase b. In contrast to the currently 
employed assays for these enzymes that measure the non-physiologically relevant reverse 
reaction of glycosidic bond synthesis and thereby require prior knowledge of not just one but 
two sugar components, this new method has the potential to greatly reduce the complexity in 
discovering the substrate specificity of a new enzyme. Certain phosphorylases can catalyze 
the degradation of glycogen into a-D-glucose-1-phosphate and are targets for the 
development of antidiabetic therapeutics. By electrospray ionization mass spectrometry 
analysis, the kinetic parameters KM, Vmax, and Kt (for a/p-D-glucose) have been determined 
for the rabbit muscle phosphorylase b. This enzyme accepts maltoheptaose, maltohexaose, 
and maltopentaose as substrates in the direction of glycogen degradation, but the 
tetrasaccharide maltotetraose cannot serve as a substrate for this phosphorylysis reaction. 
1 Reproduced with permission of Anal. Biochem. (2004), 327,107-113. Copyright 2004 
Elsevier. 
2 Graduate student and (Assistant Professor, respectively, Department of Chemistry and the 
Plant Sciences Institute, Iowa State University 
3 Primary researcher and an author 
4 Author for correspondence 
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Introduction 
Prior to the advent of comprehensive genome sequencing projects, clues to the chemical 
function of newly isolated proteins—chemical proteomics1'2—were often ascertained from 
the molecules that were isolated along with the protein of interest.3 Unfortunately, protein-
ligand binding information is lost when putative enzyme sequences are cloned from genomic 
information and heterologously expressed as required for massive proteomics projects. 
Sequence homology, while it can provide insightful evidence in narrowing possible functions 
of unknown enzymes,4 does not constitute unequivocal validation of function. The wealth of 
genomic information and the inability to rely exclusively on sequence homology to dictate 
unknown protein function point to the need for general techniques to quickly and easily 
determine the chemical function and substrate specificity of unknown enzymes.4 One 
approach is to choose a substrate and then screen it for reaction with a mix of proteins.5,6 
Conversely, a putative enzyme may be chosen and then screened for reactivity with an array 
of substrates.7 Commonly employed assays for enzyme function, especially those involving 
carbohydrates for which specific activity-based probes are unknown, often lack generality 
and rely on specially labeled substrates or indirect detection methods that require detailed 
prior knowledge of the enzyme's chemical function. On the other hand, mass spectrometry 
has the potential to screen multiple possible substrates of a protein by direct detection of 
reaction components and products without special labels. Herein we report such a general 
strategy for determining the chemical function of the class of enzymes that cleaves glycosidic 
linkages with phosphate (Scheme 5.1) using glycogen phosphorylase, an important target for 
the development of antidiabetic therapeutics, as a model system. 
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Scheme 5.1. Mass spectrometry analysis of phosphorylated product formation provides a 
general strategy to ascertain if a putative sugar phosphorylase acts on a substrate. A range of 
substrates can be screened by this method, whereas assays commonly used to probe the 
reaction in reverse would require screening of two components, thereby exponentially 
increasing the library sizes necessary. In addition, this approach is independent of the 
possible leaving groups, such as thymidine or a monosaccharide, and does not require 
separation protocols. This approach was tested with rabbit muscle phosphorylase b, which 
catalyzes the degradation of glycogen into a-D-glucose-1-phosphate. 
The class of enzymes that cleaves sugar linkages with phosphate is found in a broad range of 
genomes and is responsible for a wide variety of reactions including the breakdown of 
maltose, trehalose, sucrose, uridine and thymidine as well as carbohydrate polymers such 
starch and glycogen.3,8"14 Enzymes that degrade glycogen have attracted particular interest 
recently as targets of inhibitor design.15"18 Specifically, the synthesis and degradation of 
glycogen needs to be regulated to maintain blood glucose levels;18 therefore, the inhibition of 
the enzymes in these pathways could lead to the development of new drugs for the treatment 
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of diabetes.15 Rabbit muscle phosphorylase b, which catalyzes the reversible conversion of 
glycogen into a-D-glucose-1-phosphate (Gluc-l-P), has long served as a model for the 
human enzyme (Scheme 5.1). Since Cori and Cori3 first isolated and studied rabbit muscle 
phosphorylase, the physiological role of rabbit muscle phosphorylase has been the target of 
many investigations leading to an understanding of the control, function, and inhibition of 
this enzyme and its importance in sugar metabolism.19 This work has shown that 
phosphorylase b cleaves glycogen to within four glucosyl units of an a-l,6-linked side 
chain20'21 and that maltotetraose is the smallest primer accepted for chain elongation by this 
rabbit enzyme.19,22,23 Although various oligosaccharides of greater than three glucose units 
clearly are primers for glycogen synthesis,24'25 the minimal unit necessary for enzymatic 
degradation of unbranched oligosaccharides is still unclear. 
Traditional techniques for the determination of the inhibition of phosphorylase b demonstrate 
the problems in applying current assays for the discovery of the chemical function of putative 
phosphorylases by screening a variety of substrates. These techniques include monitoring the 
enzymatic reaction in the direction of glycogen synthesis from glycogen and a-D-glucose-1 -
phosphate via the formation of phosphate using a spectroscopic assay26 or in the direction of 
glycogen degradation by monitoring the formation of Glc-l-P using the 
phosphoglucomutase/glucose-6-phosphate dehydrogenase-coupled enzyme system.27,28 The 
coupled enzyme system presents problems when screening phosphorylase substrates and 
inhibitors since the additional enzymes also recognize similar carbohydrate structures and 
therefore require separate analytical reactions to avoid anomalous results. In fact, most 
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inhibition studies of rabbit muscle phosphorylase 616'17,28"30 and human liver phosphorylase 
an have been studied in the direction of glycogen synthesis and not the biologically relevant 
direction of glycogen degradation. In addition to the problems associated with using this 
coupled assay to screen inhibitors, this approach will only work to study enzymes that cleave 
a glycosidic linkage to form Glc-l-P; the assay is not general. 
Monitoring of the reverse synthetic reaction also poses problems. The mode of inhibition of 
the enzyme can change for some compounds when screened in the physiologically irrelevant 
direction. More importantly, study of the reverse reaction requires prior knowledge of not 
just one but two sugar components, thereby greatly increasing the complexity in discovering 
the substrate specificity of a new enzyme. In addition, the product that is produced would 
have to be characterized by additional analytical techniques. Clearly, an assay that monitors 
the forward degradation reaction and is independent of the particular chemical structure of 
the sugar phosphate is needed for the rapid discovery of substrate specificities and chemical 
functions of the many putative sugar phosphorylases uncovered by genome sequencing 
projects. 
Results and Discussion 
A general assay for a degradative sugar reaction with phosphate for chemical proteomics 
studies requires the direct detection of a sugar-1-phosphate, which lacks any strong natural 
chromophore or fluorophore. In addition to its common role in small molecule identification, 
mass spectrometry is beginning to show promise in enzymatic assays by eliminating the need 
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for synthetic bulky chromophores or fluorophores, radioactive labels, or indirect coupled 
assays.31"40 Electrospray ionization mass spectrometry (ESI-MS) is particularly useful to 
analyze species that are charged in aqueous solutions. In addition, small required sample 
sizes and autosampling capabilities render the technique ideal for scaling to high throughput. 
Indeed, with rabbit muscle phosphorylase b as a model of sugar phosphorylases, we have 
found conditions to not only determine enzyme kinetics and inhibition parameters, but also to 
screen several substrates to find the minimal sugar motif necessary for catalytic turnover in 
the degradation reaction of this enzyme. 
KM and Vmax. Through the use of ESI-MS we demonstrate the ability to monitor the 
appearance of Glc-l-P and accurately determine its concentration. To determine the kinetic 
parameters, KM and Vmax, of rabbit muscle phosphorylase b in the direction of glycogen 
degradation, the amount of Glc-l-P formed was determined with respect to inorganic 
phosphate concentration. To estimate the KM initially, the phosphate ion concentration was 
varied from 2.5 to 25 mM. With the approximate KM determined, additional kinetic data were 
obtained, from 35 to 250 mM phosphate ion concentration, to more accurately measure KM 
and Vmax. Traditional enzymatic analysis such as a Michaelis-Menten plot of the velocity 
versus phosphate ion concentration could be determined using the ESI-MS technique (Figure 
5.1). The enzymatic reactions were run in triplicate with the error bars representing the 
standard deviation from the mean. Nonlinear regression of the data yields the kinetic values 
of KM and Vmax to be 23 ± 1 mM and 40.0 ± 0.5 gmol/min/mg respectively with the R2 value 
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of the non-linear regression and double reciprocal linear Lineweaver-Burk plots to be 0.997 
and 0.995 respectively. 
Figure 5.1. Michealis-Menten and Lineweaver-Burk (inset) plots for rabbit muscle 
phosphorylase b in the direction of glycogen degradation. 
Comparison to previous techniques is difficult since there is no technique in place that is able 
to directly measure the concentration of Glc-l-P. However, the kinetic values as determined 
by ESI-MS are in the same range as the previously reported values of 2.4 - 15 mM for KM 
and 30.3 (imol/min/mg for Vmax24'26 in the direction of glycogen degradation. The slight 
deviations from the previously reported values could be the result of different protein 
preparations or the difference in direct versus indirect detection of Glc-l-P. 
40-, 
o 
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Inhibition Studies. Because liver phosphorylases regulate the degradation of glycogen into a-
D-glucose-1 -phosphate to control blood glucose levels, numerous researchers have tried to 
find inhibitors for this class of enzymes.15"18,29 However, these studies currently focus on the 
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inhibition of rabbit muscle and liver phosphorylase b in the direction of glycogen synthesis 
and not in the biologically relevant direction of glycogen degradation. The potential 
inhibition of the coupled assay by the inhibitor being studied prevents use of the current 
indirect detection assay; however, our new mass spectrometry-based assay circumvents this 
issue. 
The ESI-MS technique was tested in the presence of a/p-glucose, a previously reported 
competitive inhibitor of rabbit liver phosphorylase b in the direction of glycogen synthesis29 
and rabbit muscle phosphorlyase b41 to determine if this technique was amenable to 
inhibition studies. The velocity per milligram of protein was determined at 0, 20, and 40 mM 
a/p-glucose concentrations by measuring the amount of Glc-l-P liberated in 5 minutes at 
various phosphate concentrations. The resulting double reciprocal plot (Figure 5.2) shows the 
linear regression lines intersecting at the x-axis, indicating that glucose is a noncompetitive 
inhibitor with respect to phosphate as expected and has a Kt = 37.3 ± 0.4 mM. 
Phosphorylase Substrate Screening Studies. To show that this approach can be used to screen 
substrates for chemical proteomics studies, we probed the size of the substrates that could be 
accepted by phosphorylase b. Reactions in the direction of glycogen synthesis have shown 
that a glucose tetramer is the smallest primer that the rabbit phosphorylase b enzyme will 
1 Û O") 
accept for glycogen synthesis * ' and that phosphorylases cleave glycogen until four 
glucose units from a branch point.20"21 However, the minimal length requirement for 
polysaccharide degradation into Glc-l-P is not known. One possible reason for glycogen 
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Figure 5.2. Double reciprocal plot of 1/V vs. l/[Pi] at different phosphate concentrations for 
the degradation of glycogen by rabbit muscle phosphorylase b: 0 mM glucose (•), 20 mM 
glucose (•), 40 mM glucose (•) ([Pi] = 2.5, 5, 10, 15, 20, 25, 35, 50, 75, 100, 150, 200, and 
250 mM). 
Glc Glc Glc Glc Glc Glc Glc 
cleavage site in phosphorylase b 
B) 
cleavage site in phosphorylase b 
Scheme 5.2. Two models for substrate binding and cleavage by rabbit muscle phosphorylase 
b. A) Glycogen is cleaved to four glucose units from a branch point because the branch point 
sterically blocks access to sugars closer to the branch point. B) At least five glucose units are 
needed for the substrate to bind to the active site with a glucose unit oriented for cleavage. 
92 
degradation to cease is because the branch point sterically blocks the glycogen chain from 
moving further into the active site. Another possible explanation is that the enzyme cannot 
bind four glucose units sufficiently for catalytic turnover and therefore glycogen degradation 
ceases (Scheme 5.2). As a test of the minimal binding requirement for the degradation of 
glycogen, rabbit muscle phosphorylase b was incubated in the presence of 50 mM phosphate 
buffer and a-methyl-glucopyranoside, a polysaccharide containing two to seven glucose 
units linked a-l-»4, or glycogen. Only glycogen, maltoheptaose, maltohexaose, and 
maltopentaose acted as substrates to produce Glc-l-P as determined by ESI-MS. With 
maltotetraose as a substrate, almost no Glc-l-P was produced after 18 hours. The small 
activity seen can be attributed to the commercial sample being only 98% maltotetraose with 
the remaining amount containing larger and smaller chain polysaccharides. This experiment 
demonstrates the ability of this strategy to readily ascertain the catalytic function of a sugar 
phosphorylase by screening potential substrates. In addition, we have shown for the first time 
that rabbit muscle phosphorylase b does not degrade glycogen to less than four glucosyl units 
of a branch point simply due to steric constraints but because it is unable to degrade any 
glycogen fragment with less than four glucosyl units. 
Conclusion 
An ESI-MS-based strategy for the determination of the chemical function of sugar 
phosphorylases has been developed with phosphorylase b as a model for this family of 
carbohydrate cleaving enzymes. This new assay allows the direct detection and concentration 
determinations of the non-polymeric carbohydrates involved in the enzymatic reaction in 
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addition to the quantitative determination of kinetic parameters without concern about the 
substrate acceptances of the other enzymes required in the coupled assay cascade. This 
technique as described is as sensitive as the traditional phosphoglucomutase/glucose-6-
phosphate dehydrogenase-coupled enzyme system currently used to study phosphorylases in 
the direction of glycogen degradation. If greater sensitivity is necessary it could be achieved 
through fewer dilutions before ESI-MS analysis. In addition, this technique does not need to 
be concerned with the impact the inhibitor may have on the analytical method as is possible 
with the coupled assay. The ESI-MS technique therefore is amenable to a wide variety of 
studies with a range of inhibitors and can easily be adapted for the high throughput screening 
of inhibitors of this class of enzymes, which may serve in the study and potential treatment of 
disorders such as diabetes. This new assay also has provided clear evidence that rabbit 
phosphorylase b cannot cleave substrates shorter than five glucose units regardless of 
polymer chain branching. Because this approach is not dependent on the nature of the sugar 
phosphate or the leaving group that is cleaved, it represents the first method to now enable 
large-scale chemical proteomic studies of the broad class of genes ascribed putative functions 
as sugar phosphorylases. 
Materials and Methods 
General materials and methods. Trizma base, trizma hydrochloride, and sodium phosphate 
were purchased from Fischer Scientific Company (Hanover Park, IL). All other chemicals 
and rabbit muscle phosphorylase b (EC 2.4.1.1) were obtained from Sigma Chemical Co. (St. 
Louis, MO) unless otherwise noted and used without further purification. Nanopure water 
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(18.1 MHz) prepared from a Barnstead E-pure water purification system was employed 
throughout. 
MS Conditions, A Shimadzu LCMS 2010 quadrupole mass spectrometer (Shimadzu 
Scientific Instruments, Columbia, MD) equipped with an electrospray ionization (ESI) source 
was used in negative ion mode. The capillary temperature and the spray voltage were kept at 
220 °C and 4.5 kV, respectively. The instrument was calibrated by direct infusion of 
polyethylene glycol (PEG) 200, 600, 1000 (1.5 [iL/L, 2 (aL/L, and 15 (iL/L, respectively) and 
raffinose (50 mg/L) in water/methanol (1:1, v:v) containing ammonium acetate (0.19 mM), 
0.1% formic acid, and 0.1% acetonitrile. For sample analysis the solvent 
(acetonitrile/water/triethylamine, 35/65/0.2) was constantly infused into the ion source at 250 
|iL/min by the attached Shimadzu HPLC pump and the samples were injected (5 jjL) via the 
autosampler adapted to fit two 96-well plates. A preliminary MS chromatogram was obtained 
by scanning from 50 - 700 m/z. To increase the signal to noise ratio, the instrument was set 
for selected ion monitoring (SIM) mode and all relevant m/z ions were monitored for further 
analysis of the enzymatic reactions. Inclusion of an Agilent Extend CI8 column (2.1 x 50 
mm, Agilent, Palo Alto, CA) in the system further increased the signal to noise ratio and 
decreased the appearance of sodium ion adducts by 10-15% without separation of reaction 
components. Postrun software (LCMS Postrun version 2.02, Shimadzu Scientific 
Instruments, Columbia, MD) was used to analyze the data from the ESI-MS chromatogram. 
Peaks were integrated to determine the relative intensity of each ion species monitored as 
compared to an internal standard. 
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Kinetic Analysis 
Standard Curves. Calibration curves were run in triplicate and created by adding a-D-
glucose-1-phosphate (0.1 - 25 mM) to 50 (j,L solutions containing Tris buffer (100 mM, pH 
6.8), AMP (ImM), glycogen (6.8 mg/mL), and glucose (0, 20, or 40 mM). The samples (20 
jaL) were diluted with 20 \\L of 70% methanol/water containing UMP (1 mM) as an internal 
standard. The quenched solutions were centrifuged 10 minutes at 10,000 x g to precipitate 
the glycogen. Aliquots (15 p.L) of the reaction mixtures were diluted with 135 \xL of 
acetonitrile/water/triethylamine (35/65/0.2). These samples (5 pL) were subjected to analysis 
via ESI-MS. A plot of the resulting relative intensity of Glc-l-P (m/z = 259) as compared to 
UMP (m/z = 323) was plotted against Glc-l-P concentration and was found to fit a straight 
line (Figure 5.3). 
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Figure 5,3. Calibration curves for the relative intensity of a-D-glucose-1-phosphate (m/z = 
259) as compared to UMP (m/z = 323): 0 mM glucose (•), 20 mM glucose (•), 40 mM 
glucose (•) (R2=0.99). 
Measurement of KM and Vmax of Phosphate. The values of KM and Vmax were derived from 
enzymatic reactions run in triplicate and determined from the initial rates of glycogen 
degradation by monitoring the rate of Glc-l-P formation using ESI-MS. The reaction 
conditions were modified from a previously reported procedure.18 The enzymatic reaction 
was initiated by the addition of rabbit muscle phosphorylase b (0.025 units, 30 units/mg 
protein) to a reaction mixture containing Tris buffer (100 mM, pH 6.8), AMP (1 mM), 
glycogen (6.8 mg/mL), and phosphate (2.5 - 250 mM). Reactions were carried out at 30 °C 
and after 5 minutes 20 pL of the reaction mixture was quenched by addition to 20 pL of 70% 
methanol/water containing UMP (1 mM) as an internal standard. The quenched solutions 
were centrifuged 10 minutes at 10,000 x g to precipitate the glycogen and protein. Aliquots 
(15 |iiL) of the reaction mixtures were diluted with 135 pL of acetonitrile/water/triethylamine 
(35/65/0.2). These samples (5 pL) were subjected to analysis via ESI-MS to determine the 
Glc-1 -P concentrations. 
Product Inhibition of Phosphorylase b Using Glucose. The inhibition of rabbit muscle 
phosphorylase b with glucose was run in triplicate and was determined from the initial rates 
of glycogen degradation by monitoring the rate of Glc-l-P formation using ESI-MS. The 
enzymatic reaction was initiated by the addition of rabbit muscle phosphorylase b (0.025 U) 
to a reaction mixture containing Tris buffer (100 mM, pH 6.8), AMP (1 mM), glycogen (6.8 
mg/mL), glucose (0, 20, and 40 mM), and phosphate (2.5 - 250 mM). Reactions were carried 
out at 30 °C and after 5 minutes 20 pL of the reaction mixture was quenched by addition to 
20 pL of 70% methanol/water containing UMP (1 mM) as an internal standard. The 
quenched solutions were centrifuged 10 minutes at 10,000 x g to precipitate the glycogen and 
protein. Aliquots (15 |uL) of the reaction mixtures were diluted with 135 \iL of 
acetonitrile/water/triethylamine (35/65/0.2). These samples (5 pL) were subjected to analysis 
via ESI-MS to determine the Glc-l-P concentration. 
Substrate Screening of Phosphorylase b. The minimal binding motif of phosphorylase b was 
determined by monitoring the degradation of either a-methyl glucopyranoside or 
polysaccharides containing 2-7 glucosyl units. The enzymatic reaction was initiated by the 
addition of rabbit muscle phosphorylase b (0.025 U) to a reaction mixture containing 
phosphate buffer (50 mM, pH 6.8), AMP (ImM), and polysaccharide (6.8 mg/mL). 
Reactions were carried out at 30 °C when after 20 minutes 20 jj,L of the reaction mixture was 
quenched by addition to 20 pL of 70% methanol/water containing UMP (1 mM) as an 
internal standard. The quenched solutions were centrifuged 10 minutes at 10,000 x g to 
precipitate the glycogen and protein. Aliquots (15 pL) of the reaction mixtures were diluted 
with 135 |oL of acetonitrile/water/triethylamine (35/65/0.2). These samples (5 pL) were 
subjected to analysis via ESI-MS to determine the Glc-l-P concentration. 
Data Analysis. All kinetic data was fitted with the non-linear regression algorithm in 
GraphPad Prism version 3.03 (GraphPad Software, San Diego, CA). Error bars on the graphs 
represent the standard deviation of three independent averaged data points. 
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CHAPTER 6. Unusual Sugar Nucleotide Recognition Elements of 
Mesophilic Versus Thermophilic Glycogen Synthases 
Corbin J. Zea1,2 and Nicola L. Pohl1,3 
Abstract 
The glycogen synthase found in Pyrococcus furiosus is a hyperthermophilic biocatalyst that 
transfers the glucose portion of nucleotide-diphosphoglucose onto a growing glycogen chain 
at 80 °C. In contrast to the mesophilic rabbit muscle glycogen synthase, the biocatalyst from 
P. furiosus possesses unusually broad nucleotide tolerance. The enzyme accepts all four 
common glucose-containing nucleotide-diphosphosugars : ADP-glucose, GDP-glucose, 
dTDP-glucose, and UDP-glucose. Using an ESI-MS assay, we determined the KM and Vmax 
for GDP-glucose to be 3.9 ± 0.6 mM and 0.243 ± 0.009 mM/min and for dTDP-glucose to be 
4.0 ± 0.5 mM and 0.216 ± 0.008 mM/min. A related nucleotide sugar, UDP-galactose, was 
not a reactive substrate, but was instead a competitive inhibitor with a AT, of 17 ± 2 mM. The 
glycogen synthase from P. furiosus was shown not to have phosphorylase activity. The AÀG 
of substrate binding was compared between the mesophilic rabbit muscle and the 
hyperthermophilic P. furiosus glycogen synthase to dissect any differences in sugar 
nucleotide recognition strategies at elevated temperatures. Both biocatalysts were shown to 
gain most of their substrate affinity through electrostatic interactions between the enzyme 
and the alpha-phosphate. 
1 Graduate student and Assistant Professor, respectively, Department of Chemistry and the 
Plant Sciences Institute, Iowa State University 
2 Primary researcher and an author 
3 Author for correspondence 
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Figure 6.1. Glycogen synthases usually carry out chain elongation steps in the 
polymerization of glucose. NDP = nucleotide diphosphate. R = uridine or adenine. 
Introduction 
Glycogen synthases are crucial biocatalysts that transfer glucose from either ADP- or UDP-
glucose to glycogen, forming an al->4' linkage with no demonstrated metal dependence 
(Figure 6.1). This biochemical pathway plays important roles in glucose regulation and in 
energy storage mechanisms.1 These biocatalysts belong to the broader class of enzymes 
known as glycosyltransferases. Glycosyltransferases are key enzymes that transfer a sugar 
from a nucleotide mono- or diphosphate sugar to various substrates2,3 and have been targeted 
as promising tools in the biosynthesis of nonnatural substances.4"6 Greater exploitation of 
glycosyltransferases for synthesis requires an understanding of the origins of their substrate 
specificities. Herein, we report the first comparative binding studies with various substrate 
analogs between mesophilic and hyperthermophilic proteins of any class of 
glycosyltransferase and we demonstrate the first glycosyltransferase that has little preference 
for the nucleotide portion of the activated sugar. 
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Glycosyltransferases have been previously reported to be quite specific for the nucleotide 
portion of the substrate while exhibiting some tolerance for different sugars.3 The origin of 
these specificities is evident in the crystal structures and model studies of 
glycosyltransferases7"26 in which the nucleotide portion of the substrate is buried deep inside 
the binding domain of the enzyme, whereas the sugar interacts very little with the enzyme. 
Previous binding studies16 have shown that UDP-galactose binds nearly as well to bovine a-
1,3-galactosyltransferase as the natural substrate UDP-glucose. This relative binding 
promiscuity of the sugar portion implies that the nucleotide portion may contribute the bulk 
of the substrate binding and therefore substrate recognition. This observation has been noted 
previously in reports of the inhibition of Escherichia coli MurG27 and human a-1,3-
fucosyltransferase V28 with various nucleotides and nucleosides. Those enzymes showed 
significant inhibition by the nucleotide diphosphate portion of the natural substrate, with 
subsequent loss of inhibition upon sequential phosphate removal. 
Similarly, glycogen synthase is highly substrate selective. For example, yeast and 
mammalian glycogen synthases selectively accept UDP-glucose,29"31 and bacterial glycogen 
synthases selectively accept ADP-glucose.32 In contrast, the archaeal glycogen synthase from 
Pyrococcus furious surprisingly accepts both ADP-glucose and UDP-glucose with 
comparable affinities to produce glycogen.33 These differences in nucleotide selectivity 
between the mesostable enzymes and the hyperthermostable P. furiosus enzyme raise 
questions about possible differences in the binding contributions of sugar nucleotides to these 
proteins. To investigate these questions, we carried out systematic binding studies of sugar 
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nucleotides and portions of these substrates with glycogen synthases from P. furiosus and 
rabbit muscle. Surprisingly, even though the relative binding contribution of the nucleotide is 
the same in the thermostable enzyme when compared to the mesostable enzyme, the archaeal 
glycogen synthase can bind and turn over a range of nucleotide-diphosphoglucose substrates, 
in sharp contrast to the selectivity of mesophilic enzymes. 
Results and Discussion 
Substrate Acceptance of Glycogen Synthase from P. furiosus in the Direction of Glycogen 
Synthesis. Previously we reported the acceptance by P. furiosus glycogen synthase of ADP-
glucose and UDP-glucose with similar kinetic parameters using an assay based on ESI-MS.33 
This striking result prompted us to test the acceptance of the P. furiosus glycogen synthase 
for other naturally occurring nucleotide sugars, namely dTDP-glucose, GDP-glucose, and 
UDP-galactose, in the direction of glycogen synthesis. Thus, the P. furiosus glycogen 
synthase was incubated in the presence of glycogen and dTDP-glucose, GDP-glucose, or 
UDP-galactose for 20 min (Table 6.1). The enzyme accepted both dTDP-glucose and GDP-
glucose as substrates, but not UDP-galactose. The ESI-MS assay also allows monitoring of 
all substrates simultaneously; therefore, we were able to study the relative substrate 
acceptances in one pot. After incubation of P. furiosus glycogen synthase in the simultaneous 
presence of UDP-glucose, ADP-glucose, GDP-glucose, and dTDP-glucose for 20 min, the 
relative substrate acceptance was determined to be UDP-glucose ~ ADP-glucose > GDP-
glucose > dTDP-glucose (Figure 6.2). 
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KM (mM) VMAX (mM/min) ^/^(mM"1 s"') 
UDP-Glc 4.1 ±0.7 0.29 ±0.01 0.86 
ADP-Glc 4.1 ± 0.5 0.301 ± 0.008 0.90 
dTDP-Glc 4.0 ± 0.5 0.216 ±0.008 0.66 
GDP-Glc 3.9 ±0.6 0.243 ± 0.009 0.76 
UDP-Gal Not Accepted Not Accepted Not Accepted 
Table 6.1. Substrate acceptance of P. furiosus glycogen synthase. 
Figure 6.2. Relative acceptance of sugar nucleotides as substrates for polymerization by the 
P. furiosus glycogen synthase. 
Additional kinetic studies determined the KM and Vmax values for the P. furiosus glycogen 
synthase and dTDP-glucose to be 4.0 ± 0.5 mM and 0.216 ± 0.008 mM/min respectively, 
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whereas the values for the P. furiosus glycogen synthase with GDP-glucose were 3.9 ± 0.6 
mM and 0.243 ± 0.008 mM/min respectively. A comparison of the specificity constant, 
ha/K-M, in Table 1 indicates UDP-glucose and ADP-glucose to be the preferred substrates. 
This data fits the relative acceptance findings; ADP-glucose and UDP-glucose are turned 
over equally and more efficiently than GDP-glucose and dTDP-glucose. Partially purified 
glycogen synthases from the hyperthermophiles Thermococcus hydrothermalis34 and 
Sulfolobus acidocaldarius35 have been reported to accept both ADP-glucose and UDP-
glucose as substrates. In comparison to the known mesophilic glycogen synthases, the 
thermostable enzymes have reduced substrate selectivity. The comparable acceptance of 
UDP-glucose and ADP-glucose by the P. furiosus glycogen synthase is interesting because 
of the significant size difference between the two bases uridine and adenine. The slight 
selectivity for UDP-glucose over the similar pyrimidine base dTDP-glucose is presumably 
due to the existence of the additional methyl group found in thymine or an interaction with 
the 2'-OH. The exocyclic amine group of guanine confers additional steric bulk that may 
decrease binding of GDP-glucose to the enzyme. Structural determination promised by a 
structural proteomics efforts centered on P. furiosus proteins36 might soon shed more light on 
this issue. 
Although the substrate analog UDP-galactose was not accepted by the P. furiosus glycogen 
synthase, the reason for this selectivity was not clear. The enzyme could have evolved a 
binding pocket to sterically discriminate against substrates with an axial hydroxyl at the 4-
position of the sugar ring and prevent their binding; alternatively, the protein could have 
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scenario, analogous substrates such as UDP-galactose should bind to the protein and serve as 
inhibitors but not as substrates. To determine the ability of P. furiosus to bind UDP-
galactose, we incubated ADP-glucose in the presence of UDP-galactose. UDP-galactose was 
indeed a competitive inhibitor of P. furiosus with a Kt of 17 ± 2 mM (Figure 6.3). The 
substrate clearly binds to the active site of the enzyme, but unlike the glucose substrates, 
activated galactose is not incorporated into the polymeric product. 
20-, 
0.30 0.45 0.60 0 i 0.00 
1/[ADP-glucose] (mM)"1 
Figure 6.3. Competition experiment for ADP-glucose versus UDP-galactose for the P. 
furiosus glycogen synthase at different UDP-galactose concentrations, 0 mM (•), 10 mM 
(o), 20 mM (•). Nonlinear regression of the data yielded the Kt of UDP-galactose to be 17 ± 
2 mM. 
Phosphorylysis Activity Determination. To determine if the glycogen synthase from P. 
furiosus is capable of not only glycogen synthesis but also its degradation by phosphorylysis, 
the biocatalyst was incubated in the presence of glycogen and phosphate for 20 min. No 
evidence of glucose-1 -phosphate was detected by an ESI-MS-based assay.37 Clearly, the 
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archaeal glycogen synthase does not possess any significant phosphorylysis activity in 
addition to its primary catalytic function of synthesizing glycogen. 
Glycogen Synthase Binding Determination. To gain some insight into the reason that the P. 
furiosus glycogen synthase is less selective than other glycogen synthases, we examined the 
binding interactions between the biocatalyst and its substrates. Using conditions previously 
described38'39 to determine the Kt for various substrates, the substrate inhibition of the natural 
substrate was used to determine the AAGbinding39 for various portions of the natural substrate 
to elucidate the substrate portion most important for binding. Each enzyme substrate has a 
hydrophilic sugar portion linked by charged phosphates to a nucleoside containing an 
aromatic ring. The relative contributions of the substrate fragments to enzyme binding could 
vary slightly in going from a mesophilic to a thermophilic protein. The dielectric constant of 
water decreases from 74 to 6140,41 as the temperature changes from 37 to 80 °C; thereby, in 
hotter water electrostatic interactions become effectively somewhat stronger. 
To elucidate the substrate portion most important for binding to glycogen synthase, the 
inhibition of glycogen synthase from P. furiosus and rabbit muscle by UDP-glucose, ADP-
glucose, and various truncated versions of these substrates was determined. From the 
inhibitory constants determined for P. furiosus and rabbit muscle glycogen synthase (Table 
6.2), the differences in free energy were determined from the expression AAG = RT 
ln(Kj2/Kii), where Kn and K& are the constants for the two substrates under comparison.39 
The AAG of binding was noted for UDP-glucose, ADP-glucose, and truncated version of 
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Source Inhibitor K, (mM) 
P. furiosus UDP 5.4 ± 0.6 
UMP 6.5 ± 0.2 
U 90 ±10 
ADP 5.4 ± 0.8 
AMP 3.7 ±0.1 
A 580± 30 
glucose-1 -phosphate 124 ± 20 
glucose 290 ± 20 
rabbit muscle UDP 12 ±0.9 
UMP 6.4 ± 0.4 
U 260± 20 
Table 6.2. Inhibitory constants for P. furiosus and rabbit muscle glycogen synthase. 
V 
HO 
UDP-glucose 
fl fl 
TTV5 
OH OH 
~v 
AAG (kcal/mol) 
J 0 0.019 ±0.003 V_ 
0.19 ±0.03 0.19 ±0.03 
0.32 ± 0.03 -0.034 ±0.003 
2.2 ±0.3 3.5 ±0.4 
2.4 ±0.4 
3.0 ±0.3 
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Figure 6.4. Binding differences by P. furiosus glycogen synthase of UDP, UMP, U, ADP-
glucose, ADP, AMP, A, glucose-1 -phosphate, and glucose as compared to UDP-glucose. 
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these substrates to P. furiosus glycogen synthase (Figure 6.4). The binding loss accompanied 
by the removal of the sugar was minimal in both cases, a result that matches that previously 
seen for the bovine a-1,3-galactosyltransferase.42 For the binding of uracil-containing 
substrates, sequential loss in binding occurred with the systematic removal of phosphates 
with the largest drop upon the removal of the a-phosphate. For the binding of adenine-
containing substrates, a slight increase in binding was noted upon the removal of the (3-
phosphate. In contrast, upon removal of both phosphates the binding of adenosine changed 
greater than for uridine indicating the importance in the electrostatic binding of the 
phosphates to the protein. To determine the relative roles of the a- and (3-phosphates in 
substrate binding, we determined the inhibitory constant for glucose-1 -phosphate, which 
contains the (3-phosphate of UDP-glucose, and glucose itself containing no phosphates. A 
noticeable loss in binding occurs for glucose and glucose-1-phosphate (Figure 6.4). This loss 
in binding supports the idea that a majority of the binding of UDP-glucose for the P. furiosus 
glycogen synthase is due to the a-phosphate. However, structural studies of this enzyme 
cocrystallized with these various substrate analogs, including an unreactive carbasugar 
version of UDP-glucose,43 will be necessary to further elucidate these binding motifs. 
For rabbit muscle glycogen synthase, there also is little difference in substrate binding 
between UDP-glucose and UDP (Figure 6.5). However, as phosphates are removed from the 
nucleotide the binding energy decreases to yield the following binding order: UDP > UMP > 
U. Since little binding is lost upon removal of the sugar portion of the enzyme substrate and 
the most significant binding loss is after removal of both phosphate groups, from UMP to U, 
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the most important binding interaction for rabbit muscle glycogen synthase is also the 
electrostatic interaction between the phosphate groups and the protein. This enzyme exhibits 
substrate discrimination between ADP-glucose and UDP-glucose primarily by steric 
selection rather than significant binding interaction differences. This substrate selection may 
be of biological importance in assuring that mammalian glycogen synthases are not inhibited 
by AMP or ADP. 
UDP-glucose 
N "O 
AAG (kcal/mol) 
0.053 ±0.005 
0.45 ± 0.04 
2.3 + 0.2 
Figure 6.5. Binding differences of UDP, UMP, and U as compared to UDP-glucose by rabbit 
muscle glycogen synthase. 
In contrast to the substrate selectivity of the rabbit muscle glycogen synthase,30'31 we have 
found the P. furiosus glycogen synthase to accept all the common nucleotide diphosphate 
glucoses, ADP-, dTDP-, GDP-, and UDP-glucose, with very similar acceptance rates. 
Although this difference in substrate tolerance could reflect differences in protein binding 
affinities to the nucleobase portion of the sugar nucleotide, our binding studies do not support 
this possibility. The electrostatic interaction between the phosphates of the NDP-glucose and 
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the enzyme have the greatest impact in creating favorable substrate binding energies. Since 
undertaking this work, interactions between basic amino acid side chains of a glycogen 
synthase and the acidic phosphate groups of the NDP-sugar have been noted recently in the 
first reported structure of a glycogen synthase from Agrobacterium tumefaciens24 and in the 
modeling of the E. coli glycogen synthase.26 Unfortunately, the ability of a biocatalyst to 
bind a substrate does not necessarily correlate with its ability to turn over the substrate, as 
demonstrated by the ability of bovine a-1,3 -galactosyltransferase to bind UDP-glucose16 and 
the P. furiosus glycogen synthase to bind UDP-galactose both without performing a glycosyl 
transfer step. Therefore, static pictures formed from protein structural analyses even in the 
presence of substrates will never form a complete picture of the substrate discrimination and 
synthetic capabilities of carbohydrate-utilizing enzymes. More biochemical studies on a wide 
range of these enzymes are needed to discern the role that kinetic selection has in sugar 
substrate discrimination to maintain fidelity in carbohydrate biosynthesis. 
Materials and Methods 
Materials. The rabbit muscle glycogen synthase (EC 2.4.1.11) was obtained from Sigma (St. 
Louis, MO). The P. furiosus glycogen synthase was expressed and purified as previously 
reported.33 Isopropyl-(3-thiogalactoside (IPTG) was obtained from Labscientific (Livingston, 
NJ). Isobutyl-C-galactoside (IBCG) was synthesized in our lab as previously reported.44 All 
other chemicals were obtained from Sigma (St. Louis, MO) unless otherwise noted. 
Glycogen was purified by precipitation from a 6.8 mg/mL aqueous solution by addition of 
two volumes of a 70% methanol/water. SDS-PAGE gels (Tris 10-20% gradient, BioRad, 
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Hercules, CA) were stained with colloidal Coomassie blue. Protein concentration was 
measured by the method of Bradford,45 using bovine serum albumin as the standard. 
Enzyme Activity Determination. The enzymatic activity determination conditions were as 
previously reported.33 One unit of enzyme is defined as one p,mol UDP-glucose consumed 
per minute at the appropriate pH and temperature, pH 5.0 at 80 °C or pH 8.2 at 30°C. The 
activity of the purified P. furiosus glycogen synthase was determined by measuring how 
much UDP-glucose was consumed in 8 min as determined by ESI-MS.33 The instrument 
calibration conditions were as previously reported.33 
Standard Curves. Calibration curves of the relative intensity of the substrate (glucose-1-
phosphate, GDP-glucose, dTDP-glucose, and UDP-galactose) to the internal standard (AMP) 
were constructed over the concentration range of 1-50 mM in a manner similar to that 
previously reported.33,37 The measured substrate concentrations fell within this range. 
Measurement of KM and Vmax of GDP-glucose, dTDP-glucose, UDP-galactose for P. furious 
Glycogen Synthase. The values of KM and Vmax in the direction of glycogen synthesis were 
derived by monitoring the initial rates of substrate (GDP-glucose, dTDP-glucose, or UDP-
galactose) consumption using ESI-MS. The reaction conditions were as previously 
described.33 The enzymatic reaction was initiated by the addition of substrate (2-50 mM) to a 
reaction mixture containing acetate buffer (50 mM, pH 5.0), glycogen synthase from P. 
furiosus (0.02 U/ 50 pL) at a constant glycogen concentration (6.8 mg/mL). Reactions were 
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carried out at 80 °C and after 5 min 15 jjL of the reaction mixture was quenched by addition 
to 30 (J.L of 70% methanol/water containing AMP (3 mM) as an internal standard. The 
standard protocol for diluting and preparing reaction samples for analysis is as follows. The 
quenched solutions were centrifuged 10 min at 10,000 x g to precipitate the glycogen and 
protein. Aliquots (15 p,L) of the reaction mixtures were diluted with 135 pL of 
acetonitrile/water/triethylamine (35/65/0.2). These samples (5 (j,L) were analyzed by ESI-MS 
to determine the amount of substrate consumed. This and subsequent kinetic data were fitted 
with the nonlinear regression algorithm in GraphPad Prism version 4.0 (GraphPad Software, 
San Diego, CA). Errors bars on the graphs represent the standard deviation of three 
independent averaged points. 
Relative Substrate Acceptance of P. furiosus Glycogen Synthase. The relative acceptance of 
UDP-glucose, ADP-glucose, GDP-glucose, and dTDP-glucose was determined in one pot in 
the direction of glycogen synthesis. The enzymatic reaction was initiated by the addition of 
UDP-glucose, ADP-glucose, GDP-glucose, and dTDP-glucose (2.5 mM each) to a reaction 
mixture containing acetate buffer (50 mM, pH 5.0), glycogen synthase from P. furiosus (0.02 
U), and glycogen (6.8 mg/mL). Reactions were carried out at 80 °C and after 20 minutes 15 
|o,L of the reaction mixture was quenched by addition to 30 fiL of 70% methanol/water 
containing AMP (3 mM) as an internal standard. The solutions were diluted and prepared 
using the standard protocol described above, and the samples (5 (aL) were subjected to 
analysis via ESI-MS as previously described33 to determine the amount of UDP-glucose, 
ADP-glucose, GDP-glucose, and dTDP-glucose consumed. 
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Inhibition of P. furiosus by UDP-galactose. The value of Kt for UDP-galactose in the 
direction of glycogen synthesis was derived from enzymatic reactions by monitoring the 
initial rate of ADP-glucose consumption using ESI-MS. The reaction conditions were as 
previously described.33 The enzymatic reaction was initiated by the addition of ADP-glucose 
(2-50 mM) to a reaction mixture containing UDP-galactose (0, 10, 20 mM), acetate buffer 
(50 mM, pH 5.0), glycogen synthase from P. furiosus (0.02 U/50 pL) at a constant glycogen 
concentration (6.8 mg/mL). Reactions were carried out at 80 °C and after 5 minutes 15 pL of 
the reaction mixture was quenched by addition to 30 pL of 70% methanol/water containing 
AMP (3 mM) as an internal standard. The solutions were diluted and prepared using the 
standard protocol described above, and the samples (5 pL) were subjected to analysis via 
ESI-MS to determine the amount of ADP-glucose consumed. 
Glycogen Hydrolysis. The enzymatic reaction was run in triplicate and contained acetate 
buffer (25 mM, pH 5.0), 0.02 units of P. furiosus glycogen synthase, 50 mM phosphate, and 
6.8 mg/mL glycogen. The enzymatic reactions were allowed to incubate for 10 minutes at the 
desired temperature before the addition of glycogen. The reaction was quenched after 20 
minutes by the addition of 15 |uL of the reaction mixture to 30 |_iL of 70% methanol/water 
containing AMP (3 mM) as an internal standard. The solutions were diluted and prepared 
using the standard protocol described above, and the samples (5 juL) were subjected to 
analysis via ESI-MS as previously described34 to determine the amount of glucose-1-
phosphate produced. 
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Enzyme Inhibition by UDP, ADP, UMP, AMP, U, A, Glc-1-P, and Glc. The inhibition of the 
rabbit muscle and P. furiosus glycogen synthase enzymes in the presence of UDP-glucose or 
ADP-glucose was determined from the initial rates in the direction of glycogen synthesis by 
monitoring the rate of UDP-glucose or ADP-glucose consumption using ESI-MS. The 
enzymatic reaction was run in Tris (25 mM, pH 8.2) or acetate buffer (25 mM, pH 5.0), 0.02 
Units of enzyme, 2-50 mM UDP-glucose or ADP-glucose, the inhibitor UDP (1, 2, 4, 6 
mM), ADP (1, 2, 4, 6, mM), UMP (1.5, 2.5, 5, 10 mM), AMP (1.5, 2.5, 5, 10 mM), U (5, 10, 
20, 50 mM), A (5, 10, 20, 50 mM), glucose-1-phosphate (5, 10, 20, 50 mM), or glucose (5, 
10, 20, 50 mM), and 6.8 mg/mL glycogen. The enzymatic reactions were allowed to incubate 
for 10 minutes at 30 °C or 80 °C before the addition of UDP-glucose for uracil-containing 
inhibitors or ADP-glucose for adenine-containing inhibitors. The reaction was quenched after 
20 minutes by the addition of 15 pL of the reaction mixture to 30 \iL of 70% methanol/water 
containing UMP (3 mM, when ADP-glucose is the substrate) or AMP (3 mM, when UDP-
glucose is the substrate) as an internal standard. The solutions were diluted and prepared 
using the standard protocol described above, and the samples (5 (o,L) were subjected to 
analysis via ESI-MS as previously described33 to determine the UDP-glucose or ADP-
glucose concentration. 
Glycogen Elongation Study. To test for glycogen chain elongation and correlate the decrease 
in dTDP-glucose and GDP-glucose, the glycogen synthase reaction was set up for each 
enzyme source and substrate as described previously.33 The reaction was initiated by the 
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addition of dTDP-glucose, GDP-glucose, or UDP-galactose and quenched after 30 min by 
the addition of 50 (J.L of the reaction mixture to 100 jiL of 70% methanol/water. The 
quenched solutions were centrifuged 10 minutes at 10,000 x g to precipitate the glycogen. 
The glycogen pellet was rinsed twice with methanol (100 pL) to remove residual glucose-6-
phosphate and resuspended in water (1 mL). This sample was analyzed for glycogen content 
using a starch assay kit (SA-20, Sigma, St. Louis, MO). This assay showed that concentration 
decreases in dTDP-glucose and GDP-glucose were directly proportional to increases in the 
amount of glycogen (data not shown). 
Additional Information: Michaelis-Menten plots, inhibition plots, and inhibition constants for 
all substrates are found in the Appendix at the end of this chapter. 
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Appendix 
Michaelis-Menten plots, inhibition plots, and inhibition constants for all substrates are found 
below. Error bars represent the standard deviation of three independent trials. 
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Figure 6.6. Michealis-Menten plot in the direction of glycogen formation for P. furiosus 
glycogen synthase in the presence of GDP-glucose (•). 
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Figure 6.7. Michealis-Menten plot in the direction of glycogen formation for P. furiosus 
glycogen synthase in the presence of dTDP-glucose (•). 
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Figure 6.8. Dixon plot for the inhibition of glycogen synthase by UDP from P. furiosus in 
the direction of glycogen synthesis in the presence of UDP (1,2,4, 6 mM). 
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Figure 6.9. Dixon plot for the inhibition of glycogen synthase by UMP from P. furiosus in 
the direction of glycogen synthesis in the presence of UMP (1.5, 2.5, 5, 10 mM). 
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Figure 6.10. Dixon plot for the inhibition of glycogen synthase by uridine from P. furiosus in 
the direction of glycogen synthesis in the presence of uridine (5, 10, 20, 50 mM). 
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Figure 6.11. Dixon plot for the inhibition of glycogen synthase by ADP from P. furiosus in 
the direction of glycogen synthesis in the presence of ADP (1, 2, 4, 6, mM). 
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Figure 6.12. Dixon plot for the inhibition of glycogen synthase by AMP from P. furiosus in 
the direction of glycogen synthesis in the presence of AMP (1.5, 2.5, 5, 10 mM). 
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Figure 6.13. Dixon plot for the inhibition of glycogen synthase by adenosine from P. 
furiosus in the direction of glycogen synthesis in the presence of adenosine (5, 10, 20, 50 
mM). 
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Figure 6.14. Dixon plot for the inhibition of glycogen synthase by glucose-1-phosphate from 
P. furiosus in the direction of glycogen synthesis in the presence of glucose-1 -phosphate (5, 
10,20, 50 mM). 
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Figure 6.15. Dixon plot for the inhibition of glycogen synthase by glucose from P. furiosus 
in the direction of glycogen synthesis in the presence of glucose (5, 10, 20, 50 mM). 
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Figure 6.16. Dixon plot for the inhibition of glycogen synthase by UDP from rabbit muscle 
in the direction of glycogen synthesis in the presence of UDP (1, 2, 4, 6 mM). 
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Figure 6.17. Dixon plot for the inhibition of glycogen synthase by UMP from rabbit muscle 
in the direction of glycogen synthesis in the presence of UMP (1.5, 2.5, 5, 10 mM). 
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Figure 6.18. Dixon plot for the inhibition of glycogen synthase by uridine from rabbit 
muscle in the direction of glycogen synthesis in the presence of uridine (5, 10, 20, 50 mM). 
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CHAPTER 7. Conclusion 
What Was Learned 
We have demonstrated through substrate-metal binding studies that divalent magnesium and 
manganese play an important role in substrate binding and catalysis in sugar 
nucleotidyltransferases and glycosyltransferases. While manganese binds more tightly than 
magnesium to the substrates involved, the cellular concentration of manganese is much lower 
than that of magnesium, which dictates that the dominant species of nucleotide triphosphates 
in vivo is magnesium bound. Manganese dependant biocatalysts have a permanent binding 
site. This allows for the permanent sequestering of manganese for optimum biocatalytic 
activity. 
The ability to rapidly characterize biocatalytic activity has made the ESI-MS technique a 
powerful tool in the characterization of biocatalysts. It is amenable to traditional Michealis-
Menten kinetic analysis to determine KM and VMAX, inhibitor studies to determine KH and able 
to detect biocatalytic activity in crude sample preps. One limitation is the requirement that 
substrates of interest need to be mass differentiated. This limitation rules out the ability to 
study biocatalysts where the substrate's mass does not change, as in the class of biocatalysts 
classified as epimerases. 
Tolerance for atypical substrates depends on the nature of the biocatalyst. Archaeal glycogen 
synthase turns over all forms of NDP-glucose while not accepting the sugar counterpart 
UDP-galactose. This is in stark contrast to the highly selective nature of glycogen or starch 
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synthases from yeast and rabbit muscle. Nucleotidyltransferases are also known to be highly 
substrate-selective. The commercially available yeast sugar nucleotidyltransferase that 
preferentially accepts glucose-1 -phosphate and UTP, was shown to accept ATP. This 
acceptance was previously reported, but previously it was not demonstrated that the dual 
acceptance was not due to an impure sample preparation, but actually dual substrate 
acceptance at the same active site. This determination was not possible until the application 
of the ESI-MS technique to this system. The differences noted in substrate selectivity 
between families may correlate to the relative genome size of each organism studied. 
Future Work 
Because the ESI-MS technique is easily adaptable to various systems and substrates, further 
application of this technique to other systems is in the foreseeable future. It has been shown 
to have great advantages over traditional techniques for the characterization of sugar 
nucleotidyltransferases, glycosyltransferases, and phosphorylases. It is also applicable to 
other carbohydrate biocatalysts that may be difficult to characterize using traditional 
techniques. One limitation to this technique is the requirement for a mass change for 
biocatalyst characterization, which means epimerases and isomerases are not a viable 
candidates for characterization. This can be overcome through the use of mass differentiated 
libraries.1 
Continued characterization of biocatalysts from Archaea is of further interest. Specifically it 
would be of interest to study the glycogen synthases from Sulfolobus acidocaldaius2 and 
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Thermococcus hydrothermalis3 which previously have been shown to accept both UDP-
glucose and ADP-glucose. Also other glycogen synthases would need to be investigated so a 
more complete picture could be presented to determine to what extent are Archaea 
biocatalysts accepting of more than one substrate as was seen in the glycogen synthase from 
Pyrococcus furiosus. The continued study of substrate selectivity for other biocatalytic 
systems from archaeal sources would help to determine if all Archaea biocatalysts are as 
promiscuous as the glycogen synthase system or not. This understanding could lead to the 
better utilization of biocatalysts in industrial settings. 
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